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ABSTRACT 
Humans are exposed to a variety of persistent organic pollutants (POPs) that have been 
spread to the environment because of various human activities. Food is the main source 
of exposure to most POPs. Many POPs are lipid-soluble, accumulate in the human 
body and are easily transferred to the fetus and to breastfed infants through breast milk. 
POPs have been shown to cause a number of adverse effects in animals, including 
effects on reproduction, development and on endocrine, nervous and immune systems.  
The overall aims of this thesis were to quantify body burdens of POPs in pregnant and 
nursing women in Sweden and to study whether current maternal, fetal or infant 
exposure to POPs is associated with birth weight or markers of thyroid function.  
First-time mothers were recruited in Uppsala, Sweden between 1996 and 2010 (POPUP 
cohort). Samples (breast milk or blood) from the participating women were analysed 
for polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxin and dibenzo-
furans (PCDD/Fs) and polybrominated diphenyl ethers (PBDEs). Thyroid hormones 
were analysed in maternal and infant blood. Data on lifestyle factors and diet were 
collected by interviews and questionnaires. 
The results showed that levels of PCBs and PCDD/Fs in breast milk decreased with 4-
8% per year during the study period. Temporal trends for PBDEs varied depending on 
congener studied, with decreasing levels of BDE-47, -99 and -100 (5-10% per year) 
and slightly increasing levels of BDE-153 (1% per year). High maternal age and fast 
weight loss after delivery predicted higher levels of PCBs and PCDD/Fs in breast milk, 
whereas a high pre-pregnancy body mass index and large weight gain during pregnancy 
predicted lower levels. Women who were breastfed during infancy, grew up on the east 
coast of Sweden and had a high consumption of contaminated fatty Baltic fish during 
the year before pregnancy had higher levels of some POPs in breast milk. 
Prenatal exposure to di-ortho PCBs (estimated by breast milk levels) was significantly 
associated with higher birth weight, whereas breast milk levels of PBDEs were 
associated with lower birth weight. The mean difference in birth weight between the 
25th and 75th percentiles of exposure was approximately 100 g for di-ortho PCBs and  
-80 g for PBDEs. 
Associations between exposure to PCBs, PCDD/Fs and PBDE and thyroid hormone 
levels in mothers during pregnancy and in infants after delivery were weak and non-
significant in most cases. However, a higher maternal body burden of PCDD/Fs was 
associated with lower maternal levels of triiodothyronine (T3). This association was 
similar in early and late pregnancy, which strengthens its reliability. 
Altogether, this thesis provides knowledge about exposure to POPs in Swedish first-
time mothers that is useful in risk assessments of POPs in food. The margins between 
current body burdens of POPs and the levels tolerable from a health perspective are in 
some cases small or non-existent. In addition, the observed associations between POP 
exposure and birth weight and thyroid hormone status may be of importance for public 
health. Hence, it is desirable that body burdens of PCBs, PCDD/Fs and PBDEs in 
Swedish women continue to decrease. Efforts to reduce contamination of the 
environment and of the food chain should therefore be continued. Monitoring of POP 
levels in breast milk is an important tool to follow-up human POP exposure. 
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1 BACKGROUND 
 
1.1 INTRODUCTION 
Persistent organic pollutants (POPs) are halogenated compounds that accumulate in the 
environment and in the human body because of their lipid solubility and resistance to 
chemical and biological degradation. They have been intentionally produced for different 
purposes or have been formed inadvertently during certain chemical processes. Examples 
of POPs are industrial chemicals (e.g., polychlorinated biphenyls, PCBs), chlorinated 
pesticides (e.g., dichlorodiphenyl-trichloroethane, DDT), brominated flame retardants 
(BFRs) (e.g., polybrominated diphenyl ethers, PBDEs) and by-products (e.g., dioxins 
(polychlorinated dibenzo-p-dioxins, PCDDs and polychlorinated dibenzofurans, PCDFs)) 
(Figure 1). Food is the main source of human exposure to most POPs. They are easily 
transferred to the fetus during pregnancy and breastfed infants are exposed to high levels 
from breast milk. 
 
 
Figure 1. Chemical structures of polychlorinated biphenyls (PCBs), polychlorinated dibenzo-p-dioxins 
(PCDDs), polychlorinated dibenzofurans (PCDFs), p,p’-dichlorodiphenyl-trichloroethane (p,p’-DDT), the 
DDT-metabolite p,p’-dichlorodiphenyl-dichloroethylene (p,p’-DDE) and polybrominated diphenyl ethers 
(PBDEs). 
 
In experimental studies in animals POPs have been shown to cause various effects on 
reproduction and development, as well as effects on the endocrine, nervous and immune 
systems (Darnerud 2003; Larsen 2006). The fetus is most sensitive to exposure, with 
children seemly more sensitive than adults (Baccarelli et al. 2005). In humans, accidental 
exposure to high levels of PCBs and dioxins early in life causes, among other things, 
dermal lesions, retarded growth, delayed cognitive development and effects on 
reproduction (Aoki 2001; Guo et al. 2004). Similar but more subtle effects have been 
indicated in populations with background exposure to these substances (Langer 2008; 
Lundqvist et al. 2006; Schantz et al. 2003). 
 
Because of their unwanted properties, the use, production and release of many POPs have 
been strongly controlled since the 1970s. Not surprisingly, the levels of many POPs have 
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decreased in the environment and in food (Bignert et al. 2012; Glynn et al. 2000; Ålander 
et al. 2012). However, POPs still persist in the environment and in the human body and 
therefore pose a possible threat to human health. In addition, for POPs that are still used 
by the industry or are still found in consumer products, the temporal trends may be 
increasing. For instance, the levels of some BFRs increased in the environment and in 
breast milk in Sweden from the 1970s to the 1990s (Bignert et al. 2012; Norén and 
Meironyte 2000).  
 
To protect the Swedish consumers from high exposure to PCBs and dioxins the Swedish 
National Food Agency (NFA) has issued consumption advisories since the 1980s 
concerning certain fish species known to contain high levels of these chemicals (e.g. wild 
Baltic Sea salmon and Baltic Sea herring). The main objective of the advisories is to 
protect humans during their most sensitive periods of life, i.e. the fetal and infant periods 
and childhood. Accordingly, advisories regarding contaminated fish are directed to 
children and women in childbearing ages. By limiting the accumulation of PCBs and 
dioxins in women before they get pregnant, the fetus and infant are protected from high 
exposure to these substances. The most recent revision of the advisories for fish with high 
levels of dioxins and PCBs was conducted in 2007 (Ankarberg et al. 2007). The current 
recommended maximum consumption of such products as Baltic Sea herring and salmon 
for children and women in childbearing age is 2-3 times per year. For other groups, the 
recommended maximum consumption is once a week (NFA 2013). 
 
The basis for this thesis is a study of POPs in Swedish first-time mothers that was 
initiated in 1996 at the NFA. The study was later given the name POPUP (Persistent 
Organic Pollutants in Uppsala Primiparas). In 1996, the scientific basis of consumption 
advisories regarding contaminated fish had just recently been revised. The conclusion 
reached by the NFA was that data on POP exposure of Swedish pregnant and nursing 
women were scarce. The POPUP study was thus started to improve basic data for future 
risk assessments of POPs in food. 
 
The specific POPs studied in this thesis are PCBs, dioxins (PCDD/Fs), the DDT-
metabolite p,p’-dichlorodiphenyl-dichloroethylene (p,p’-DDE) and PBDEs (Figure 1). 
 
 
1.2 SOURCES OF POPs 
 
1.2.1 PCB and PCDD/F 
The industrial PCB production started in the late 1920s. At that time, PCBs were 
manufactured as chemical mixtures under different trade names (e.g., Aroclor and 
Clophen) (Bernes 1998). PCB products were highly appreciated because of their good 
insulating and plasticizing ability as well as their high temperature resistance. The 
majority of PCBs were used as dielectric fluids in transformers and capacitors, but they 
also had a number of other applications, such as ingredients in paints, sealants, lubricants 
and plastics (Bernes 1998; Erickson and Kaley 2011). In Sweden, the use of PCBs in new 
products has been restricted since 1972 and the use of old products containing PCBs was 
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prohibited in 1995 (Bernes 1998). PCB production and use have also been restricted in 
other parts of the world since the 1970s. 
 
PCDDs and PCDFs (commonly called “dioxins”) are unintentionally formed as by-
products during different industrial processes, such as production of chlorinated chemicals 
and bleaching of pulp and paper using chlorine and during incomplete combustion in for 
example waste incinerators (Rappe 1996). Although the emissions of dioxins have been 
greatly reduced since the 1980s, there are still diffuse sources of emission to the 
environment (e.g., uncontrolled backyard burning of waste).  
 
1.2.1.1 The TEF-system 
Depending on degree and pattern of chlorination, there are 75 possible PCDD congeners 
and 135 possible PCDF congeners (Figure 1). Seventeen of these congeners are 
chlorinated in 2,3,7,8-position and of toxicological concern. These congeners bind to and 
activate the aryl hydrocarbon receptor (AhR) and thereby elicit their toxic responses. 
Among the 209 possible PCB congeners, 12 non-ortho- and mono-ortho-substituted 
congeners also have the capability to bind to the AhR and are thus dioxin-like (DL). The 
remaining PCB congeners are named non-dioxin-like (NDL). 
 
PCDD/Fs and PCBs are found as complex mixtures in almost all matrices. To facilitate 
comparisons of analytical data and risk assessment of 2,3,7,8-substituted PCDD/Fs and 
DL-PCBs the World Health Organization (WHO) has established the toxic equivalency 
factor (TEF) concept. To be included in the TEF system a congener must 1) show a 
structural relationship to the PCDDs and PCDFs, 2) bind to the AhR, 3) elicit AhR-
mediated biochemical and toxic responses and 4) be persistent and accumulate in the food 
chain (Van den Berg et al. 2006). Each DL compound has been assigned a TEF based on 
its potency relative to the potency of the most toxic dioxin, 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) (Table 1). By multiplying the concentration of each congener by its TEF 
and then adding the resulting concentrations, the toxic equivalent (TEQ) concentration of 
a mixture can be calculated. WHO TEF values were established in 1998 (Van den Berg et 
al. 1998) and reevaluated in 2006 (Van den Berg et al. 2006) (Table 1). 
 
1.2.2 PBDE 
PBDEs are included in a diverse group of chemicals called BFRs. They have been used in 
various materials to increase fire resistance since the beginning of the 1970s. Major uses 
have been in high-impact polystyrene, acrylonitrile butadiene styrene plastic, flexible 
polyurethane foam, textile coatings, wire and cable insulation and in electronics (WHO 
1994). Some consumer products containing PBDEs include computers, home electron-
ics, cars, furniture, building materials and textiles. 
 
There are 209 possible PBDE congeners with a different number and pattern of bromine 
(Figure 1). The three commercial PBDE mixtures mostly used are named after the 
number of bromines in the molecules of the dominating components: pentaBDE, 
octaBDE and decaBDE. The pentaBDE and octaBDE mixtures have been banned with-
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in the EU since 2004 (EU 2003b) and decaBDE was banned in electric and electronic 
equipment in 2006 (EU 2003a). 
 
 
Table 1. Summary of WHO 1998 and 2006 TEF values for dioxin-like compounds. Bold values indicate  
a change in TEF value between 1998 and 2006. 
Compound WHO 1998 TEFa WHO 2006 TEFb 
Chlorinated dibenzo-p-dioxins   
 2,3,7,8-TCDD 1 1 
 1,2,3,7,8-PeCDD 1 1 
 1,2,3,4,7,8-HxCDD 0.1 0.1 
 1,2,3,6,7,8-HxCDD 0.1 0.1 
 1,2,3,7,8,9-HxCDD 0.1 0.1 
 1,2,3,4,6,7,8-HpCDD 0.01 0.01 
 OCDD 0.0001 0.0003 
Chlorinated dibenzofurans   
 2,3,7,8-TCDF 0.1 0.1 
 1,2,3,7,8-PeCDF 0.05 0.03 
 2,3,4,7,8-PeCDF 0.5 0.3 
 1,2,3,4,7,8-HxCDF 0.1 0.1 
 1,2,3,6,7,8-HxCDF 0.1 0.1 
 1,2,3,7,8,9-HxCDF 0.1 0.1 
 2,3,4,6,7,8-HxCDF 0.1 0.1 
 1,2,3,4,6,7,8-HpCDF 0.01 0.01 
 1,2,3,4,7,8,9-HpCDF 0.01 0.01 
 OCDF 0.0001 0.0003 
Non-ortho-substituted PCBs   
 3,3’,4,4’-tetraCB (PCB 77) 0.0001 0.0001 
 3,4,4’,5-tetraCB (PCB 81) 0.0001 0.0003 
 3,3’,4,4’,5-pentaCB (PCB 126) 0.1 0.1 
 3,3’,4,4’,5,5’-hexaCB (PCB 169) 0.01 0.03 
Mono-ortho substituted PCBs   
 2,3,3’,4,4’-pentaCB (PCB 105) 0.0001 0.00003 
 2,3,4,4’,5-pentaCB (PCB 114) 0.0005 0.00003 
 2,3’,4,4’,5-pentaCB (PCB 118) 0.0001 0.00003 
 2’,3,4,4’,5-pentaCB (PCB 123) 0.0001 0.00003 
 2,3,3’,4,4’,5-hexaCB (PCB 156) 0.0005 0.00003 
 2,3,3’,4,4’,5’-hexaCB (PCB 157) 0.0005 0.00003 
 2,3’,4,4’,5,5’-hexaCB (PCB 167) 0.00001 0.00003 
 2,3,3’,4,4’,5,5’-heptaCB (PCB 189) 0.0001 0.00003 
aVan den Berg et al., 1998. bVan den Berg et al., 2006.  
 
 
1.2.3 DDT 
In the 1940s to 1960s, the insecticide DDT was widely used in agriculture and for malaria 
control. Most of the developed countries banned or restricted the use of DDT in the 
1970s. The main reason for banning DDT was the observed adverse effects on 
reproductive success in wild animals (Beard 2006). In Sweden, the relatively low use of 
DDT was banned in agriculture in 1970 though spraying of forests was allowed for 
another five years (Bernes 1998). DDT is still used in malaria-infested areas of the world 
where human exposure remains high. In the environment and in humans DDT is mainly 
found as the extremely stable metabolite p,p’-DDE (Figure 1). Because of their persis-
tence, DDT and its metabolites are found in biological samples throughout the world.  
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1.3 HUMAN EXPOSURE TO POPs 
There are several cases of accidents in which certain human populations have been 
exposed to high levels of POPs. For example, an accident in a trichlorophenol 
manufacturing plant near the Italian town of Seveso in 1976 exposed the population in 
the vicinity to very high levels of TCDD (Bertazzi et al. 1998). Accidents have also 
occurred in which food items have been contaminated. The most well-known cases are 
the severe PCB and dioxin poisonings in Yusho (Japan, 1968) and Yu-Cheng (Taiwan, 
1979), both caused by accidental contamination of rice oil (Aoki 2001). 
 
For the general population, food is the main source of exposure to most POPs. Because 
of their lipid solubility and persistence, POPs bioaccumulate throughout the food webs 
and food of animal origin contain the highest levels. For instance, more than 90% of the 
human exposure to dioxins are estimated to come from food, and of this, at least 75% 
normally come from food of animal origin (Liem et al. 2000). For BFRs, indoor air and 
dust are other important sources of exposure (Johnson-Restrepo and Kannan 2009; 
Lorber 2008). 
 
1.3.1 POP levels in food and intake levels 
Many POPs that are spread to the environment finally end up in aquatic environments. 
Hence, investigations of PCDD/Fs, PCBs, p,p’-DDE and PBDEs in food on the 
Swedish market show that fatty fish contain the highest levels (Ankarberg et al. 2007; 
Törnkvist et al. 2011). The levels in other food of animal origin are generally lower, 
with fruit and vegetables containing the lowest concentrations (Ankarberg et al. 2007). 
Fatty wild-caught fish from the Baltic Sea and from the Swedish lakes Vänern and 
Vättern (e.g., herring, salmon and brown trout) contain the highest levels; specific 
levels, however, vary depending on location and size of the fish (Ankarberg et al. 2007; 
Cantillana and Aune 2012). The levels of PCDD/Fs, PCBs and p,p’-DDE in the marine 
environment have decreased since the 1970s, and declining trends in food of animal 
origin have been observed for the period 1990-2010 (Bignert et al. 2012; Glynn et al. 
2000; Ålander et al. 2012). However, indications show that the levels of PCDFs in 
marine biota have stabilized at the levels around 1990 (Bignert et al. 2012). The levels 
of PBDEs in the marine environment increased from the late 1960s until the early 
1990s. Though the trends are inconsistent, they have mainly decreased thereafter 
(Bignert et al. 2012). 
 
The NFA has performed several estimations of the Swedish population’s POP intake 
from food. These estimations have either been based on food consumption surveys or 
on market basket studies (trade statistics). The studies have shown decreasing intakes of 
PCDD/Fs, PCBs, p,p’-DDE and PBDEs from the late 1990s up to 2010 (Darnerud et al. 
2006; NFA 2011; NFA 2012; Törnkvist et al. 2011). The median daily intake of total 
TEQ (sum of PCDD/F TEQs and DL-PCB TEQs) in adults decreased from 1.1 to 0.5 
pg/kg body weight between 1998-1999 and 2010 (Figure 2). Fish and shellfish 
contributed to the largest part of the average dietary intake of total TEQ (69%), 
followed by dairy products (17%) and meat (7%) (NFA 2011). For NDL-PCBs, PBDEs 
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and p,p’-DDE, fish and shellfish were also the largest contributors to the average dietary 
intake (about 40-70%) as calculated from a market basket study in 2010 (NFA 2012). 
 
 
 
Figure 2. Calculated median total TEQ (sum of PCDD/F TEQs and DL-PCBs TEQ) intakes from 
Swedish food consumption surveys conducted in 1997-1998 (adults) (Ankarberg and Petersson-Grawé 
2005), 2010 (adults) (NFA 2011) and 2003 (children) (NFA 2011). Intakes in infants are based on breast 
milk levels from first-time mothers in Uppsala (Bergkvist et al. 2010). TEF values from 1998 (Van den 
Berg et al. 1998) and data on PCDD/Fs and PCBs in food from 1990-2000 were used in the intake 
calculations for adults in 1997-1998. TEF values from 2006 (Van den Berg et al. 2006) and data on 
PCDD/Fs and PCBs in food from 2000-2010 were used in calculations for adults in 2010 and children in 
2003. TEF values from 2006 were used in the calculations of intakes in infants. 
 
 
Children are generally exposed to higher levels of POPs from food than adults, mainly 
because they eat more per kg body weight (Figure 2). Because of a relatively high lipid 
content, breast milk contains high levels of POPs. Exposure of breastfed infants is thus 
considerably higher than dietary exposure of children and adults (Figure 2). Based on 
levels of dioxins and PCBs in breast milk from the POPUP study, the mean intake of 
total TEQ in newborn infants can be estimated to be about 40-80 times higher than the 
intake from food in Swedish children (Bergkvist et al. 2010). The intakes decrease during 
the breastfeeding period because of a decrease in milk consumption per kg body weight 
by the infants. In addition, a monthly reduction in the levels of dioxins and PCBs in breast 
milk is assumed because lactation is an elimination pathway for POPs for women. 
 
1.3.2 Body burdens of POPs in humans 
POPs are generally well absorbed from the gastrointestinal tract. The absorption of 
PCDD/Fs and PCBs is dependent on degree of chlorination, but has been shown to be 
nearly complete in breastfed infants and between 50 and 90% in adults (Dahl et al. 1995; 
Larsen 2006). Because of their high lipid solubility and resistance to metabolism, POPs 
accumulate in the body during an individual’s lifetime, chiefly in adipose tissue. 
Therefore, measured POP levels in body lipids are the result of long-term exposure before 
the sampling occasion. During pregnancy, the compounds are easily distributed from the 
mother to the fetus via the placenta, and after delivery from the maternal blood to the 
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milk. The half-lives of PCDD/Fs, PCBs and PBDEs in the human body are dependent on 
the degree of chlorination or bromination and on the position of the halogen atoms in the 
molecule. Reported half-lives range from a few months up to several decades (Geyer et al. 
2004; Milbrath et al. 2009). The transfer from maternal blood to milk generally decreases 
with increasing chlorination or bromination (Mannetje et al. 2012; Wittsiepe et al. 2007).  
 
Body burdens of POPs are often measured in lipids in different tissues and organs since 
there is equilibrium between levels in the lipids in different compartments. In pregnant 
and nursing women POPs may be analysed in maternal blood, cord blood, placenta or 
breast milk. High correlations between lipid-adjusted levels of both chlorinated and 
brominated POPs in these different matrices have been reported (Ayotte et al. 2003; 
Mannetje et al. 2012; Needham et al. 2011; Wittsiepe et al. 2007). This finding indicates 
that POP levels in any of the matrices give a good estimate of the maternal body burden 
during pregnancy and thus of the exposure of the infant during the fetal and nursing 
periods. Breast milk is a good matrix for POP analysis because it estimates maternal body 
burden and because the sampling of breast milk is non-invasive and relatively simple. 
 
1.3.2.1 Determinants of POP body burdens 
There are large interindividual differences in body burdens of POPs. Several personal 
characteristics and lifestyle factors (determinants) may contribute to these differences. 
One of the strongest determinants is age, higher body burdens of PCBs, dioxins and p,p’-
DDE in older individuals have been reported in several studies (Hardell et al. 2010; 
Herbstman et al. 2007; Schade and Heinzow 1998; Wittsiepe et al. 2007). In other 
lifestyle factors, a high body mass index (BMI) at sampling has been shown to predict 
lower breast milk levels of PCBs in nursing women (Albers et al. 1996) and weight loss 
in obese individuals has been associated with higher blood levels of PCBs and p,p’-DDE 
(Chevrier et al. 2000). Blood levels of PCBs and p,p’-DDE in children have also been 
shown to decrease with increasing body weight and BMI, and blood levels of PCBs, 
dioxins and p,p’-DDE are higher in males than in females (Jonsson et al. 2005; Karmaus 
et al. 2001; Link et al. 2005; Nawrot et al. 2002). Smoking generally predicts lower breast 
milk or blood levels of PCBs and dioxins (Garabrant et al. 2009; Hedley et al. 2006; 
Uehara et al. 2007), possibly because of an increased metabolism and elimination rate in 
smokers (Flesch-Janys et al. 1996).   
 
Pregnancy and breastfeeding are two important elimination routes for POPs in women. 
Indeed, inverse associations between parity/breastfeeding and POP levels in breast milk 
and blood have been repeatedly demonstrated (Hardell et al. 2010; Schade and Heinzow 
1998; Vaz et al. 1993). Breastfed infants are exposed to high levels of POPs from breast 
milk. In this respect, several studies have shown that nursing affects serum levels of 
PCBs, dioxins and p,p’-DDE in children from infancy up to adolescence (Karmaus et al. 
2001; Lackmann et al. 2004; Link et al. 2005; Nawrot et al. 2002; Patandin et al. 1997).  
 
Several studies have reported positive associations between fish consumption and body 
burdens of PCBs, dioxins and p,p’-DDE, both in Sweden (Jonsson et al. 2005; Rylander 
et al. 2009) and in other countries (Agudo et al. 2009; Schade and Heinzow 1998). Fish 
consumption has also been associated with serum levels of PBDEs (Thomsen et al. 2008), 
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but exposure from the indoor environment is also supported by a positive association 
between breast milk and dust levels of PBDEs (Karlsson et al. 2007; Wu et al. 2007).  
 
1.3.2.2 Temporal trends 
Risk management decisions with the aim to reduce environmental contamination and 
human exposure to POPs have been followed up by investigations of temporal trends of 
POP exposure in the Swedish population. In accordance with the decreasing levels in the 
environment and in food, levels of PCBs, dioxins and p,p’-DDE in breast milk from 
Swedish mothers have decreased by at least 70% from the beginning of the 1970s up to 
about 2000 (Meironyté Guvenius 2002; Norén and Meironyte 2000). Decreasing trends of 
PCBs and p,p’-DDE have also been found in blood and adipose tissue from middle-aged 
Swedish men and women during the period 1993-2007 (Hardell et al. 2010). In contrast, 
levels of PBDEs in breast milk have increased since the 1970s, at least up to the end of 
the 1990s when the levels seem to have stabilized or even declined (Fangstrom et al. 
2008; Meironyte et al. 1999; Meironyté Guvenius 2002). It is important to continue 
following the levels of POPs in breast milk to determine whether measures taken to 
reduce environmental and human exposure will also result in decreasing levels in the 
future. 
 
Although there are differences between countries, levels of PCBs, dioxins and chlorinated 
pesticides in breast milk from Sweden are in the same range as those found in other 
European countries and in North America and Asia (Glynn et al. 2012; van Leeuwen and 
Malisch 2002). Regarding PBDEs, Swedish breast milk levels are in the same range as 
those found in other European countries. Human levels of PBDEs in North America are 
considerably higher, probably because of the extensive use of PBDEs in a variety of 
consumer products (Glynn et al. 2012; Schecter et al. 2005). 
 
 
1.4 HUMAN HEALTH EFFECTS 
 
1.4.1 Health risk assessments 
 
1.4.1.1 PCDD/Fs and DL-PCBs 
Several international expert groups have conducted risk assessments of PCDD/Fs and 
DL-PCBs in food (JECFA 2002; SCF 2000; SCF 2001; WHO 2000a). These risk 
assessments identified the fetal stage as the most sensitive period, and health-based 
tolerable intake levels for humans are based on animal studies of effects after in utero 
exposure. 
 
In 2001, EU’s expert group (Scientific Committee on Food, SCF) determined a tolerable 
weekly intake (TWI) of 14 pg TEQ/kg body weight, corresponding to a tolerable daily 
intake (TDI) of 2 pg TEQ/kg body weight for TCDD (SCF 2001). The TWI was extended 
to include all PCDD/F and PCB congeners with assigned TEF values (Van den Berg et al. 
1998) and was based on the effects on sperm production and sexual behavior in male rats 
after exposure during the fetal stage. An uncertainty factor of 9.6 was applied. WHO’s 
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expert group for food additives and contaminants (JECFA) used the same critical study as 
SCF in a risk assessment conducted in 2001 and reached a provisional tolerable monthly 
intake of 70 pg TEQ/kg body weight, which can be converted to a TDI of 2.3 pg TEQ/kg 
body weight (JECFA 2002).  
 
The above-mentioned tolerable intake levels relate to the body burden in women of 
childbearing ages and are set to protect fetuses from too high exposures by limiting the 
long-term accumulation of dioxins and DL-PCBs in women before pregnancy. Body 
burden during pregnancy is the result of dioxin exposure (mainly from food) over an 
individual’s lifetime; short-term intakes above the tolerable probably do not have any 
health consequences. SCF and WHO conclude that exposure in breastfed infants will 
exceed the tolerable levels, but because the breastfeeding period is short and associated 
with beneficial effects, breastfeeding should be promoted (SCF 2000; WHO 2000a). 
 
Recently, the US Environmental Protection Agency (US-EPA) conducted a risk 
assessment of non-cancer effects of TCDD (US-EPA 2012). Two human epidemiological 
studies were chosen as a basis for deriving a reference dose (RfD) (Baccarelli et al. 2008; 
Mocarelli et al. 2008). Both studies include the human population that was exposed to 
high levels of TCDD after the industrial accident in Seveso (Italy) in 1976. Critical effects 
identified were increased levels of thyroid stimulating hormone (TSH) in newborns 
exposed to TCDD in utero (Baccarelli et al. 2008) and decreased sperm count and 
motility in men who were 1-9 years old at the time of the Seveso accident (Mocarelli et al. 
2008). The estimated lowest observed adverse effect level (LOAEL) was 0.02 ng/kg body 
weight/day in both studies; after applying an uncertainty factor of 30, US-EPA proposed a 
RfD for TCDD of 0.7 pg TEQ/kg body weight/day (US-EPA 2012). 
 
The Swedish NFA and the Institute of Environmental Medicine (Karolinska Institutet, 
Sweden) conducted a risk assessment of non-developmental exposure to PCDD/Fs and 
DL-PCBs (Hanberg et al. 2007). Based on cancer studies in rats, it was concluded that the 
risk for cancer in humans is probably very small or non-existent at a long-term daily 
exposure of 2-10 pg TEQ/kg body weight. 
 
The International Agency for Research on Cancer (IARC) has evaluated information 
about carcinogenicity of PCDD/Fs and PCBs. From this evaluation, the IARC classified 
TCDD as a human carcinogen (Group 1) in 1997 (McGregor et al. 1998). Because of 
lack of human and animal data, it was not possible to classify the other PCDD/F 
congeners. In a later reevaluation 2,3,4,7,8-PeCDF and PCB 126 were also classified as 
carcinogenic to humans (Baan et al. 2009). In 2013, DL-PCBs and NDL-PCBs were 
classified as carcinogenic to humans (Lauby-Secretan et al. 2013). It was concluded that 
the carcinogenicity of PCBs cannot solely be attributed to the carcinogenicity of DL-
PCBs. 
 
1.4.1.2 NDL-PCBs 
In 2005, the European Food Safety Authority (EFSA) conducted a risk assessment of the 
sum of six NDL-PCBs (PCB 28, 52, 101, 138, 153, 180) (EFSA 2005). No health-based 
tolerable intake level could be established because it was not possible to distinguish 
 10 
between effects of NDL-PCBs from effects of DL-PCBs and dioxins in toxicological and 
epidemiological studies. The limited toxicological data on individual NDL-PCB 
congeners showed that effects on liver and thyroid were most sensitive. Based on these 
effects, the EFSA estimated that 500 µg/kg was a conservative NOAEL (no observed 
adverse effect level) body burden for total NDL-PCBs. NOAEL is the highest level that 
does not cause an adverse health effect in the most sensitive species. It was concluded that 
the median body burden in European countries (50 µg/kg body weight) was only about 10 
times lower than the NOAEL body burden. From epidemiological studies, the EFSA 
concluded that there are indications of subtle neurodevelopmental effects in infants after 
fetal exposure to NDL-PCBs, DL-PCBs and dioxins, either separately or in combination 
(EFSA 2005). These effects may occur at maternal body burdens just slightly higher than 
those expected from the average daily intake in European countries. 
 
1.4.1.3 PBDEs 
In 2011, the EFSA assessed the human health risks with a dietary intake of PBDEs 
(EFSA 2011). Main targets for PBDE toxicity were the liver as well as the thyroid 
hormone, reproductive and nervous systems. Effects on neurodevelopment in mice were 
identified as the critical effect. The EFSA derived benchmark doses (BMDs) and their 
corresponding lower 95% confidence limits for a benchmark response (neuro-
developmental effect) of 10% (BMDL10): 309 µg/kg body weight (BDE-47), 12 µg/kg 
body weight (BDE-99) and 83 µg/kg body weight (BDE-153). The BMDs were derived 
from studies in which PBDEs were administered to mouse pups on a single occasion in 
early postnatal life. Based on the calculated BMDL10 values, and considering an oral 
absorption of 75% in rodents, body burdens at the BMDL10 of 232 (BDE-47), 9 (BDE-99) 
and 62 (BDE-153) μg/kg body weight were derived. Human daily intake levels 
corresponding to the BMDL10 body burdens were estimated to 172 (BDE-47), 4.2 (BDE-
99) and 9.6 (BDE-153) ng/kg body weight. Because of the limited and uncertain database, 
the EFSA did not derive any health-based tolerable intake levels. Instead, margin of 
exposure (MOE) quotients were calculated by dividing the human intakes associated with 
the BMDL10 body burdens by the estimated dietary intake in the population. The EFSA 
concluded that the MOEs for BDE-47 and BDE-153 did not indicate any health concern 
as regards current dietary exposure within the EU, whereas the MOEs for BDE-99 indi-
cated a potential health concern, especially in young children (1-3 years) (EFSA 2011).  
 
1.4.1.4 DDT 
WHO’s expert group on pesticide residues in food (JMPR) revised the provisional TDI 
for DDT compounds in 2000 to 10 µg/kg body weight (JMPR 2001). This provisional 
TDI was based on developmental effects (reproduction) in rats (an uncertainty factor of 
100 was applied). In another WHO risk assessment of indoor residual spraying with DDT 
it was concluded that body burdens of DDT compounds below 1 µg/g lipids are safe from 
a human health perspective (carcinogenicity, developmental and reproductive effects) 
(WHO 2011).  
 
DDT/DDE were evaluated by IARC in 1991, where enough evidence was gathered to 
classify the compounds as animal carcinogens (IARC 1991). Data on humans, however, 
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were insufficient, which led to DDT/DDE being classified as possibly carcinogenic to 
humans (Group 2B). 
 
1.4.2 Influence of POPs on birth weight 
The risk assessments of dioxins, PCBs, PBDEs and DDT described above are mainly 
based on other developmental effects than birth weight. However, birth weight is a 
commonly used variable in epidemiological studies of exposure to environmental 
contaminants and health, because it is easily measured, routinely recorded and a good 
marker for fetal and infant health. 
 
1.4.2.1 Determinants of birth weight 
Poor maternal nutrition and health are the main causes of low birth weight in developing 
countries with insufficient socio-economic conditions (UNICEF and WHO 2004). 
However, among substantially healthy and well-nourished mothers, gestational length is a 
very strong predictor of birth weight (Niklasson and Albertsson-Wikland 2008). Infants 
with low birth weight are often premature, but there are also small full-term infants, often 
called growth-retarded. Except for gestational length, several other factors are known to 
predict birth weight and thus should be considered as potential confounders in 
epidemiological studies. For example, offspring birth weight increases with increasing 
maternal pre-pregnancy BMI, weight gain during pregnancy, education and parity 
(Escartin et al. 2013; Mortensen et al. 2008; Stamnes Koepp et al. 2012). On the other 
hand, high or low maternal age, smoking during pregnancy and use of alcohol or drugs 
are associated with increased risk of having small infants, with female infants being 
smaller than male infants (Cnattingius 2004; Cnattingius et al. 1992; Goldenberg et al. 
1997; Ko et al. 2002). Several medical conditions, both those existing before pregnancy 
(e.g., pre-existing hypertension) and those that emerge during pregnancy (e.g., gestational 
hypertension and preeclampsia), have been linked to an increased risk of having low birth 
weight babies (Delgado-Rodriguez et al. 1998; Easterling et al. 1991; Goldenberg et al. 
1997). Among dietary habits, maternal seafood consumption has been positively 
associated with birth weight (Brantsaeter et al. 2012). It has been suggested that long-
chain omega-3-fatty acids, abundant in fatty fish, may be responsible for this association, 
either by enhancing fetal growth or prolonging gestation (Larque et al. 2012; Olsen et al. 
1993; Olsen et al. 1990; Olsen et al. 2006). 
 
1.4.2.2 Epidemiological findings 
Women accidentally exposed to very high levels of PCBs and PCDD/Fs before pregnancy 
delivered babies with decreased birth weights (Tsukimori et al. 2012). Studies have also 
shown an inverse association between background exposure to PCBs, PCDD/Fs and p,p’-
DDE and birth weight (e.g., Fein et al. 1984; Halldorsson et al. 2008; Karmaus and Zhu 
2004; Patandin et al. 1998). However, other studies have failed to find any significant 
associations (e.g., Gladen et al. 2003; Grandjean et al. 2001; Longnecker et al. 2005). In a 
recent meta-analysis that included 12 European birth cohorts, background exposure to 
PCB 153 (a marker of total PCB), but not p,p’-DDE, is suggested to be associated with 
decreased birth weight (Govarts et al. 2012). In Sweden, birth weight in relation to PCB 
exposure has been studied in a cohort of professional fishermen and their families 
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(Rylander et al. 1998). Maternal blood plasma levels of PCB 153 during the year of 
childbirth were modeled from actual levels measured in the mothers 4-22 years later. 
These levels were later used to estimate fetal exposure. Results differed depending on the 
particular model used, but an increased risk of giving birth to infants with low birth 
weight with increasing exposure level was indicated (Rylander et al. 1998). No Swedish 
studies are available on POP exposure in relation to birth weight where the levels of POPs 
have been measured in connection with pregnancy or delivery. 
 
Few studies exist on the association between PBDE exposure and birth weight. No or 
inverse associations have actually been reported (Chao et al. 2007; Foster et al. 2011; 
Harley et al. 2011; Mazdai et al. 2003; Tan et al. 2009; Wu et al. 2010). Some of the 
studies are very small (N=12-41) (Chao et al. 2007; Mazdai et al. 2003; Tan et al. 2009) 
or report only simple correlations (Mazdai et al. 2003; Wu et al. 2010). However, two 
larger studies adjusting the results for possible confounding factors reported inverse 
associations. Foster et al. (2011) reported an inverse association between BDE-99 in 
umbilical cord serum and birth weight in a study of 97 Canadian mothers. In another 
study, Harley et al. (2011) reported inverse associations between BDE-47, BDE-99 and 
BDE-100 in maternal serum and birth weight in a cohort of 286 mothers from California.  
 
1.4.2.3 Birth weight and infant and adult health 
Birth weight is not only a marker for fetal and infant health, but also predicts health in 
adults. Low birth weight in relation to gestational length has been associated with 
increased risks of adult obesity, coronary heart disease, stroke, hypertension, type-2 
diabetes, kidney failure and cancer (Calkins and Devaskar 2011). In addition, high birth 
weight has been related to obesity, insulin resistance, hypertension and cancer (Calkins 
and Devaskar 2011). In these cases prenatal experiences, as reflected in birth weight, are 
considered important for the development of the adult disease. This concept of “fetal 
origins of adult disease” was first hypothesized by David Barker, who observed 
associations between low birth weight and cardiovascular disease (Barker 1990; Barker 
2006; Calkins and Devaskar 2011). It is thought that the fetus is able to adapt to the 
environment during development and that adaptions to malnutrition (in low birth weight 
fetuses) lead to persistent alterations in structure, physiology and metabolism that will 
affect susceptibility to disease later in life (Osmond and Barker 2000). This is also called 
“fetal programming”. Malnutrition is not the only stimulus that may result in such 
alterations during fetal life: infections, hypoxia, stress, toxins and endocrine status may 
also be important factors (Calkins and Devaskar 2011; Lau and Rogers 2004). 
Accordingly, effects of exposure to environmental contaminants during the fetal period, 
manifested as changes in birth weight, may cause permanent changes that are of 
importance for future health. 
 
1.4.3 Influence of POPs on thyroid hormones 
The complex thyroid hormone system in animals has been shown to be vulnerable to 
disruption by high exposure to a variety of POPs through changes in hormone production, 
transport or metabolism. Because the chemical structure of several POPs and their 
metabolites closely resembles that of thyroid hormones, attention has been paid to their 
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possible effects on thyroid hormone status (Brucker-Davis 1998). Effects of many POPs 
on thyroid function are well documented in experimental studies in laboratory animals. 
PCBs, dioxins and PBDEs have all been shown to reduce levels of circulating thyroid 
hormones (mainly thyroxine, T4) and increase the levels of TSH (Boas et al. 2009; 
Brucker-Davis 1998; Hallgren et al. 2001; Zhou et al. 2001). Some epidemiological 
studies have also reported associations between exposure to POPs and thyroid hormone 
status in humans (see section 1.4.3.2 below).  
 
1.4.3.1 Thyroid hormone function in humans 
The thyroid hormones, thyroxine (T4) and triiodothyronine (T3) (Figure 3), regulate a 
wide array of biological functions in the human body, including development, growth and 
metabolism. They are also essential for normal brain development during the fetal period, 
infancy and childhood (Williams 2008; Zoeller and Rovet 2004).  
 
 
 
 
 
 
 
Figure 3. Left: Illustration of the thyroid hormone axis (simplified). TSH is produced in the pituitary gland 
through stimulation by hypothalamic TRH. Circulating TSH reaches the thyroid gland, where it stimulates 
release of T3 and T4. The system is balanced through negative feedback of T3 and T4. Right: Chemical 
structures of T3 and T4. 
 
 
T4 and T3 are synthesized in the thyroid gland in response to pituitary TSH, which is 
formed following stimulation by a thyrotropin-releasing hormone (TRH), produced in the 
hypothalamus. The production of thyroid hormones is regulated by a negative feedback of 
T3 and T4 at both the hypothalamic and pituitary level (Figure 3). T4 and T3 contain four 
and three iodine atoms, respectively. Adequate dietary intake of iodine is therefore 
essential for normal thyroid hormone status. T4 is the major hormone produced by the 
thyroid. T3 is the biologically active hormone and is mostly derived from peripheral 
deiodination of T4. T3 and T4 in the blood are bound to transporter proteins, mainly to 
thyroxine-binding globulin (TBG) and, to a lesser extent, to transthyretin (TTR) and 
albumin.  
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Because the fetal production of thyroid hormones does not begin until gestational week 
14-16, the fetus is initially dependent on the passage of maternal circulating thyroid 
hormones through placenta (Patel et al. 2011). This transfer, as well as other hormonal 
and metabolic changes during pregnancy, requires an increased production of thyroid 
hormones in the mother. Maternally derived T4 is converted to active T3 within the fetal 
brain, a conversion essential for early brain development (de Escobar et al. 2004). Severe 
maternal and congenital hypothyroidism (thyroid hormone deficit) caused by iodine 
deficiency is associated with impaired neurodevelopment. Studies have revealed that 
hypothyroid fetuses suffer various postnatal disorders, including mental retardation, 
deafness and spasticity (Chen and Hetzel 2010; Trumpff et al. 2013). There is also 
evidence that even mild or moderate reductions in maternal thyroid hormone levels in 
early pregnancy are associated with impaired brain development (Glinoer and Delange 
2000; Haddow et al. 1999; Trumpff et al. 2013). European studies have shown that low 
blood levels of T4 during early pregnancy (defined as the 10th lowest percentile of free T4 
of the study sample of pregnant women) are associated with impaired cognitive 
development in children (Trumpff et al. 2013). Adequate levels of thyroid hormones in 
newborns and young infants are also essential because this is a period of active brain 
development (Glinoer and Delange 2000). Elevated neonatal TSH levels at birth have 
been associated with impaired intellectual or psychomotor development in early child-
hood (Trumpff et al. 2013). 
 
Studies on the impact of maternal thyroid status during pregnancy on thyroid function in 
the offspring in later life are scarce. However, a study of 16-year-old children showed that 
serum levels of TSH and free T4 were in accordance with maternal levels during 
pregnancy (Pakkila et al. 2013). Moreover, maternal hypo- and hyperthyroidism during 
pregnancy was associated with modified TSH levels in these children. 
 
Concern about possible effects of POPs on thyroid hormone function has been raised, 
mainly because of the importance of thyroid hormones for neurodevelopment. PCBs and 
PBDEs effect behavior and learning in mice after neonatal exposure (Branchi et al. 2005; 
Eriksson et al. 2006; Viberg et al. 2003) and neurotoxic effects have also been suggested 
in epidemiological studies (Grandjean and Landrigan 2006). It can therefore be speculated 
that POPs exert their neurotoxic effects during development by interfering with thyroid 
hormone function. 
 
1.4.3.2 Epidemiological findings 
The association between background exposure to chlorinated POPs (particularly PCBs) 
and thyroid hormone levels in humans has been studied extensively. These studies have 
been reviewed in several recent publications (Boas et al. 2006; Boas et al. 2009; 
Goodman et al. 2010; Hagmar 2003; Jugan et al. 2010; Langer 2008; Salay and Garabrant 
2009). Thyroid hormones in relation to PBDE exposure remains a considerably less well 
studied area. 
 
Several studies in pregnant women have shown an inverse relation between exposure to 
chlorinated POPs (PCBs, dioxins or p,p’-DDE) and circulating levels of T3 or T4 
(Alvarez-Pedrerol et al. 2009; Chevrier et al. 2008; Koopman-Esseboom et al. 1994; 
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Lopez-Espinosa et al. 2009; Takser et al. 2005). However, there are also studies reporting 
no significant association between maternal levels of PCBs, dioxins and p,p’-DDE and 
thyroid hormones (Dallaire et al. 2009; Lopez-Espinosa et al. 2009; Steuerwald et al. 
2000; Wilhelm et al. 2008). 
 
As mentioned earlier in this thesis, the US-EPA based their RfD for dioxins and DL-
PCBs on an epidemiological study showing a positive association between maternal 
plasma levels of dioxins and DL-PCBs at delivery and neonatal blood levels of TSH 
(Baccarelli et al. 2008; US-EPA 2012). Included in the study were infants born in 1994-
2005 by mothers who were exposed to high levels of TCDD after the 1976 industrial 
accident in Seveso (Italy). The exposure levels in the Seveso study were very high, but 
several other studies have investigated the association between background exposure to 
chlorinated POPs and thyroid hormone levels in infants and children. Studies on dioxins 
and DL-PCBs (N=23) are summarized in detail by Goodman et al. (2010). The authors 
conclude that there is no clear relation between background exposure to DL compounds 
and thyroid endpoints in infants and children. Results differ substantially in studies in 
which thyroid hormones were measured in cord blood or in infant blood within two 
weeks after birth. Reported associations between T4 and T3 and PCBs, dioxins and p,p’-
DDE are mainly non-significant (e.g., Dallaire et al. 2008; Dallaire et al. 2009; 
Longnecker et al. 2000; Sandau et al. 2002; Steuerwald et al. 2000; Takser et al. 2005), 
although some studies found significant inverse associations (Asawasinsopon et al. 2006; 
Herbstman et al. 2008; Koopman-Esseboom et al. 1994; Maervoet et al. 2007; Wang et al. 
2005). Non-significant associations with TSH are also commonly reported (e.g., Dallaire 
et al. 2009; Herbstman et al. 2008; Longnecker et al. 2000; Lopez-Espinosa et al. 2010; 
Maervoet et al. 2007; Ribas-Fito et al. 2003) although significant positive associations 
were found in a few investigations (Alvarez-Pedrerol et al. 2008; Chevrier et al. 2007; 
Koopman-Esseboom et al. 1994; Sauer et al. 1994).  
 
Only a limited number of studies of PBDE exposure and thyroid hormones in pregnant 
women could be found. Some of the studies included a very small number of participants 
(N≤25) (Kim et al. 2012; Mazdai et al. 2003; Zota et al. 2011). However, one larger study 
(N=270) reported inverse associations between tri- to hexa-brominated PBDEs and TSH 
in maternal serum sampled about the 27th week of gestation (Chevrier et al. 2010). No 
significant association was observed with T4. In contrast, maternal late pregnancy serum 
levels of tetra- to hexa-brominated PBDEs in 137 women were positively associated with 
T4, but not related to TSH (Stapleton et al. 2011). 
 
As in the case of pregnant women, the number of studies of PBDE exposure in relation to 
thyroid hormones in infants is limited. Five larger studies (N>50) that also adjusted the 
results for potential confounders were found. Two of these studies only analysed TSH in 
infant serum soon after birth and found no significant associations with maternal body 
burdens of tetra- to hexa-brominated PBDEs (Chevrier et al. 2011; Eggesbo et al. 2011). 
In three studies thyroid hormones were analysed in cord blood (Herbstman et al. 2008; 
Lin et al. 2011; Shy et al. 2012). In a US study, some evidence of inverse associations was 
noted between tetra- to hexa-brominated PBDEs in cord serum and levels of T4 
(Herbstman et al. 2008). In contrast, a Taiwanese study found a positive association 
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between hexa-brominated BDE-154 in breast milk and cord T4, but an inverse association 
with penta-brominated BDE-99 (Shy et al. 2012). In the same Taiwanese cohort, Lin et al. 
(2011) found decreasing levels of cord T3 with increasing levels of hexa- and hepta-
brominated PBDE congeners in cord blood. 
 
Taken together, studies on associations between background POP exposure and thyroid 
hormones in pregnant women and infants are clearly inconsistent. Yet, several studies 
suggest inverse associations between chlorinated POPs and T3 or T4 in pregnant women. 
The number of studies on PBDEs is small and the results often point in different 
directions. Differences in results cannot be easily explained by differences in exposure 
levels. Instead, large differences in study design such as matrices used for analysis of 
POPs (maternal blood, cord blood, infant blood, breast milk) and thyroid hormones 
(maternal blood, cord blood, infant blood), sampling time, specific substances and thyroid 
hormones chosen for analysis and statistical models (e.g., selection of confounders) may 
be at least partly responsible for the discrepancies. No Swedish studies have been 
conducted on the association between POP exposure and thyroid hormone status in 
pregnant women or infants. 
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1.5 AIMS  
The overall aims of this thesis were to quantify body burdens of POPs in pregnant and 
nursing women in Sweden (POPUP cohort) and to study whether maternal, fetal or infant 
exposure to POPs is associated with birth outcomes and markers of thyroid function. 
 
Specific objectives were to: 
 
• quantify individual breast milk levels of POPs in nursing women in Sweden to 
improve risk assessments (Paper I). 
 
• follow up if risk management measures to decrease human exposure still have an 
effect on breast milk levels of POPs in Swedish nursing women by studying how 
these levels have changed during the study period (1996-2010) (Paper I). 
 
• investigate whether personal characteristics and lifestyle factors known to be 
important determinants of breast milk levels of POPs (Paper II) may be used to advise 
women about how to reduce their body burdens. Such determinants are also important 
because they may confound the association between exposure and health effects. 
 
• study whether prenatal exposure to chlorinated and brominated POPs is associated 
with birth weight in the POPUP cohort and if possible associations between POP 
exposure and birth weight are modified by maternal fish consumption (Paper III). 
 
• determine whether exposure to chlorinated and brominated POPs is associated with 
thyroid hormone status in mothers and infants from the POPUP cohort (Paper IV&V). 
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2 SUBJECTS AND METHODS 
 
2.1 STUDY POPULATION AND SAMPLING 
This thesis is based on the POPUP cohort (Persistent Organic Pollutants in Uppsala 
Primiparas), a population of first-time mothers recruited in Uppsala County from 1996 
and onwards. The recruitment is still ongoing, but the work in this thesis is based on the 
period 1996-2010. The study can be divided into two parts (Figure 4). During the first part 
of the study (1996-1999), pregnant women were recruited among controls in a case-
control study of risk factors for early miscarriages in women born in Uppsala County 
(Cnattingius et al. 2000). To increase the number of participants from the coastal regions 
a complementary recruitment was conducted at the antenatal care clinic in Östhammar on 
the East Coast of Uppsala County. A total of 325 women donated blood samples in early 
(week 6-12) and late (week 32-34) pregnancy. After delivery, the participating women 
were asked whether they were willing to donate a breast milk sample and whether a blood 
sample could be taken from their infants at 3 weeks and 3 months of age. In all, 211 
mothers agreed to donate breast milk and blood was sampled from 160 infants at 3 weeks 
and 115 infants at 3 months. 
 
 
 
 
Figure 4. Flow-chart over the POPUP cohort. 
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In 2000-2010, 210 mothers were randomly recruited (after delivery) among first-time 
mothers who had a normal delivery at Uppsala University Hospital and were Swedish by 
birth (Figure 4). These mothers donated breast milk and blood 3 weeks after delivery. 
 
During the whole study period (1996-2010), breast milk was sampled at home during the 
third week after delivery (day 14-21 post-partum) using a manual breast milk pump or a 
passive breast milk sampler. The women were instructed to sample milk both in the 
beginning and in the end of the breastfeeding sessions. The goal was to sample 500 ml 
milk from each mother during seven days of sampling. The milk was kept in the home 
freezer in acetone-washed glass bottles and newly sampled milk was poured on top of the 
frozen milk.  
 
The POPUP cohort was restricted to first-time mothers because nursing is an important 
elimination route for POPs and thus an important determinant of the body burden of POPs 
in women. In the second part of the study (2000-2010) women who were born in non-
Nordic countries were also excluded because they may differ from women born in the 
Nordic countries regarding exposure and body burdens. In both parts of the study data on 
lifestyle factors and diet were collected by in-person interviews and by self-administered 
questionnaires (Figure 4). Data were also obtained from the Swedish Medical Birth 
Register at the National Board of Health and Welfare. The study was approved by the 
local ethics committee of Uppsala University and participants gave their informed consent 
before inclusion in the study. 
 
 
2.2 ANALYSES OF POPs IN BREAST MILK AND SERUM 
POPs were analysed in maternal serum and breast milk collected from the participants. A 
short summary of the analytical methods follows below. In some cases different methods 
and laboratories have been used during the study period. Calibration studies have been 
performed to compare the results from different methods/laboratories.   
 
Individual breast milk samples were analysed for NDL-PCBs (PCB 28, 52, 101 and the 
di-ortho substituted congeners: PCB 138, 153 and 180), DL-PCBs (mono-ortho 
substituted congeners: PCB 105, 118, 156, 167 and non-ortho substituted congeners: PCB 
77, 126, 169), seventeen 2,3,7,8-substituted PCDD/Fs, p,p’-DDE and five PBDE 
congeners (BDE-47, -99, -100, -153, -154). Late pregnancy serum samples collected 
during the first part of the study (1996-1999) were analysed for NDL-PCBs, mono-ortho 
PCBs and p,p’-DDE. 
 
In most cases, PCBs, p,p’-DDE and PBDEs were analysed at the NFA according to a 
previously described method (Atuma et al. 2000; Atuma and Aune 1999; Aune et al. 
1999; Lind et al. 2003). After extraction and separation, the final analyses of NDL-PCBs, 
mono-ortho PCBs and p,p’-DDE were performed on a gas chromatograph with dual 
capillary columns of different polarity and dual electron-capture detectors. Non-ortho 
PCBs (in samples from 2000-2004) and PBDEs were analysed by gas chromatog-
raphy/low resolution mass spectroscopy/electron capture negative ionization and detected 
by the single ion monitoring (SIM) technique. In samples from 2008-2010, all PCBs were 
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analysed by gas chromatography coupled to high-resolution mass spectrometry (Aune et 
al. 2012).  
 
PCDD/Fs (all samples) and non-ortho PCBs (samples from 1996-1999 and 2006-2010) 
were analysed at the National Institute of Public Health and the Environment (RIVM), the 
Netherlands, at the Department of Chemistry at Umeå University or at the NFA. The 
samples were analysed according to validated procedures consisting of milk sample 
extraction, clean-up and fractionation on a series of different chromatographic columns 
(e.g., multi-layer silica, alumina, Florisil and active carbon), and identification and 
quantification of the analytes using gas chromatography with high-resolution mass 
spectrometry in SIM-mode using isotope dilution technique (Aune et al. 2012; Lignell et 
al. 2009).  
 
The total lipid content of each sample was determined gravimetrically after the extraction. 
All samples were fortified with internal standards before extraction to correct for 
analytical losses and ensure quality control. A number of control samples were analysed 
together with the samples to verify the accuracy and precision of the measurements. The 
laboratory at the NFA is accredited and has successfully participated in several 
international proficiency tests. 
 
 
2.3 ANALYSES OF THYROID HORMONES IN SERUM 
Free thyroxine (free T4), total triiodothyronine (total T3) and TSH were analysed in early 
and late pregnancy serum samples from the mothers (N= 220 and 281, respectively) and 
in infant serum samples collected 3 weeks and 3 months after delivery (N=150 and 115, 
respectively). Thyroid hormones were measured on an automatic immunoassay system 
(Autodelfia, Wallac Oy, Turku, Finland). The analyses were performed at the routine 
laboratory of the Department of Clinical Chemistry at the Uppsala University Hospital. 
The laboratory is certified by a Swedish government authority (Swedac). 
 
 
2.4 DATA ANALYSIS 
Lipid-adjusted breast milk and serum levels of POPs were used in all statistical analyses 
because these levels give a good estimate of the maternal body burden during pregnancy 
and, consequently, of the exposure of the fetus and breastfed infant (Ayotte et al. 2003; 
Needham et al. 2011). In addition, POP levels were logarithmically transformed because 
the distribution of data closely followed a log-normal distribution. 
 
In Paper I, temporal trends of PCBs, PCDD/Fs and PBDEs in breast milk were 
investigated by simple and multiple regression analysis. In the multiple models the trends 
were adjusted for maternal age, pre-pregnancy BMI, weight gain during pregnancy and 
weight loss from delivery to breast milk sampling. Because of the logarithmic 
transformation of the POP-levels, the associations were presented as percent change of 
concentration per year, and not as change in absolute levels. PCDD/F TEQs and PCB 
TEQs were calculated using both 1998 and 2006 TEFs (Van den Berg et al. 1998, Van 
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den Berg et al. 2006) and the results obtained with the different systems were subse-
quently compared. 
 
In Paper II, hierarchical clustering (HC) was used to identify compounds with similar 
patterns in breast milk levels based on correlations between levels of single compounds. 
Multiple linear regression was performed to analyse associations between levels of PCBs, 
PCDD/Fs and PBDEs in breast milk and independent variables (personal characteristics) 
suspected to be determinants of breast milk levels. A three-step procedure was 
implemented. In a “basic model” (step 1) six independent variables that have been shown 
to be associated with serum and breast milk levels of POPs were included as explanatory 
variables (Glynn et al. 2007; Lignell et al. 2009; Schade and Heinzow 1998). These 
variables were maternal age, sampling year, pre-pregnancy BMI, weight gain during 
pregnancy, weight loss after delivery and education. In step 2 additional possible 
predictor variables (see Table 1 in Paper II) were added one by one to the basic model. 
Finally, all variables significantly associated with breast milk levels of POPs in step 1 and 
step 2 were included in “total models” (step 3).  
 
In Paper III, breast milk levels of di-ortho PCBs and PBDEs were employed to estimate 
prenatal exposure. Associations between prenatal exposure and birth weight were 
investigated by simple and multiple linear regression models. In the crude analyses the 
associations between di-ortho PCBs or PBDEs and birth weight were examined in 
separate models. In the adjusted model di-ortho PCBs and PBDEs were included 
simultaneously. In addition, covariates included in the adjusted model were maternal age, 
pre-pregnancy BMI, weight gain during pregnancy, education, smoking during pregnancy 
and sex of the child. These variables have all been associated with birth weight (Bailey 
and Byrom 2007; Brynhildsen et al. 2009; Cnattingius et al. 1992; Goldenberg et al. 1997; 
Mortensen et al. 2008; Newburn-Cook and Onyskiw 2005). The influence of including 
gestational length and maternal fish consumption to the statistical models was also 
investigated. To study possible sex differences in the relation of birth weight to exposure, 
all models were run for male and female infants separately. 
 
In Paper IV and V, associations between POP exposure (PCBs, PCDD/Fs, p,p’-DDE, 
PBDEs) and thyroid hormone status in mothers and infants were investigated using linear 
regression models. 
 
In Paper IV, maternal body burdens and prenatal exposure to NDL-PCBs, mono-ortho 
PCBs, PCDD/Fs and p,p’-DDE were estimated from maternal serum levels in late 
pregnancy or from breast milk levels. Postnatal exposure of the infants was calculated 
from levels in breast milk (on fresh weight basis) and percentage of full breastfeeding (see 
Paper IV for a detailed description of the calculations of postnatal exposure). Associations 
between body burden/exposure and thyroid hormone status in late pregnancy and in 
infants (3 weeks and 3 months of age) were investigated (Table 2). In cases when 
statistically significant associations were found in simple regression analyses, multiple 
regression models were used to adjust the associations for potential confounders. 
Independent variables included in the adjusted models were maternal age, pre-pregnancy 
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BMI, education, smoking, alcohol consumption, breastfeeding, season of sampling, sex of 
the infant, birth weight and infant weight at 3 months. 
 
 
Table 2. Associations between POP exposure and thyroid hormone levels in maternal and infant blood 
investigated in Paper IV and V. The table indicates in what paper (IV or V) the results are presented. 
POP exposure basis Maternal THa in 
early pregnancy 
Maternal THa in 
late pregnancy 
Infant THa at 
3 weeks 
Infant THa at 
3 months 
Maternal serum levels in late pregnancyb 
LPCB V IV IV IV 
Di-ortho PCB V IV IV IV 
Mono-ortho PCB TEQ V IV IV IV 
p,p’-DDE V IV IV IV 
Maternal breast milk levels 3 weeks after deliveryb 
PCDD/F TEQ V IV IV IV 
PBDE V V V V 
Postnatal exposureb, c 
LPCB    V 
Di-ortho PCB    V 
Mono-ortho PCB TEQ    V 
PCDD/F TEQ    V 
p,p’-DDE    V 
aAnalysed thyroid hormones in serum were free T4, total T3 and TSH. bLPCB=sum of the low-chlorinated 
PCB congeners PCB 28, 52 and 101; di-ortho PCB=sum of PCB 138, 153 and 180; mono-ortho PCB 
TEQ=sum of PCB 105, 118, 156 and 167 TEQ; PCDD/F TEQ=sum of TEQs for the 17 congeners with 
WHO TEFs; PBDE=PBDE congeners BDE-47, BDE-99, BDE-100 and BDE-153 and the sum of these 
congeners; cPostnatal exposure calculated from breast milk levels and % of full breastfeeding. 
 
 
In Paper V, maternal late pregnancy serum levels or breast milk levels were used to 
estimate maternal body burdens of NDL-PCBs, mono-ortho PCBs, PCDD/Fs and p,p’-
DDE during pregnancy as well as fetal and infant exposure (Table 2). Thyroid hormones 
were analysed in maternal early pregnancy serum. Thus, the associations between 
exposure to PCBs, PCDD/Fs and p,p’-DDE and late pregnancy thyroid hormones (studied 
in Paper IV) could be expanded by investigating early pregnancy thyroid hormones. In 
addition, associations between maternal and infant thyroid hormone levels and maternal 
PBDE body burdens were studied. After a crude analysis, a number of possible 
confounders were considered for inclusion in the model (maternal age, country of birth, 
pre-pregnancy BMI, education, smoking, alcohol consumption, maternal weight gain 
during pregnancy, season of sampling, gestational length, mode of delivery, sex of the 
infant, birth weight, number of days between delivery and sampling and infant weight at 3 
months). Covariates that were associated with any of the maternal or infant outcomes 
(p≤0.05) in the bivariate models were included in the final models. 
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3 RESULTS AND DISCUSSION 
 
This section summarizes and discusses the main results of this thesis. For a detailed 
description of the results, the reader is referred to the separate papers.  
 
3.1 TEMPORAL TRENDS OF POPs IN BREAST MILK (PAPER I) 
In Paper I, temporal trends of PCBs, PCDD/Fs and PBDEs in breast milk were 
investigated. Samples from 1996 to 2006 were included in the results and were analysed 
for NDL-PCBs (N=325), mono-ortho PCBs (N=325), non-ortho PCBs (N=220), 
PCDD/Fs (N=183) and PBDEs (N=276). 
 
3.1.1 PCB and PCDD/F 
Levels of all PCB congeners and PCDD/F TEQs decreased significantly during the study 
period. Results for some of the PCB congeners as well as PCDD/F TEQs are shown in 
Table 3. The mean decrease in PCB levels varied between 3 and 9% per year. PCDD 
TEQ levels decreased faster than PCDF TEQ levels, with estimated annual decreases of 7 
and 5% per year, respectively. Differences in declining rates between congeners may be 
due to differences in human exposure, in persistence of different congeners but may also 
be due to uncertainties in results for congeners with many results below the limit of 
quantification (LOQ). 
 
Since the publication of Paper I, new data on POPs in breast milk from 2008 to 2010 has 
been generated within the POPUP study. Updated temporal trends have been estimated 
(Lignell et al. 2012) and are presented in Table 3 and Figure 5. Similar annual changes for 
the period 1996-2010 as for 1996-2006 indicate that the decreasing trends of PCBs and 
PCDD/Fs have continued after 2006. 
 
Previous studies of PCBs and PCDD/Fs in pooled breast milk samples from Stockholm, 
Sweden have shown substantial decreasing levels from the beginning of the 1970s up to 
1997 (Norén and Meironyte 2000; Vaz et al. 1993). Our results demonstrate that the 
downwards trends, although slower, have continued after 1997 (Figure 6).  
 
Declining trends of chlorinated POPs in breast milk concur with observed decreasing 
levels in food on the Swedish market since the beginning of the 1990s (Glynn et al. 2000; 
Törnkvist et al. 2011; Ålander et al. 2012). Consequently, efforts to reduce contamination 
of the environment and of food have been successful, resulting in reduced human 
exposure. However, levels of PCDD/Fs in guillemot eggs and in herring from some areas 
in the Baltic Sea region have not decreased during the last decades, indicating that the 
levels of PCDD/Fs may no longer decrease in the Baltic Sea environment (Bignert et al. 
2012). Continuous measurements of dioxins in breast milk will show if human exposure, 
and consequently levels in breast milk, will also stabilize at the current level. 
 
Because we sampled breast milk from individual mothers, it was possible to statistically 
adjust the temporal trends for personal characteristics (maternal age, pre-pregnancy BMI, 
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weight gain during pregnancy and weight loss after delivery). In most cases this 
adjustment resulted in slightly faster declining rates. Maternal age was the most important 
covariate. There were positive associations between maternal age and breast milk levels 
of PCBs and PCDD/Fs in the POPUP cohort. In addition, maternal age increased during 
the study period and the increasing age of the mothers thus counteracted the decreasing 
temporal trends in the unadjusted regression models. This observation highlights the 
importance of age adjustment in studies of temporal trends of POPs in humans. 
 
A comparison of TEQ levels calculated with the TEFs from 1998 and 2006 (Van den 
Berg et al. 1998; Van den Berg et al. 2006), revealed that the new TEFs resulted in some 
changes in median TEQ levels (see Table 1, Paper I). However, similar temporal trends 
for PCDD/F TEQs, mono-ortho PCB TEQs and non-ortho PCB TEQs were observed 
regardless of the TEF system used. 
 
 
Table 3. Annual changes (% per year) in concentrations of POPs in breast milk from first-time mothers in 
the POPUP cohort. Data for 1996-2006 from Paper I (Lignell et al. 2009). New data are included in the 
1996-2010 trends (Lignell et al. 2012).  
Substance Simple regressiona Multiple regressionb 
 1996-2006 1996-2006 1996-2010 
 Mean (SE) Mean (SE) Half-timec Mean (SE) Half-timec 
PCB 28 -4.3* (1.4) -3.9*  (1.4) 17 -3.6*  (0.7) 19 
PCB 138 -6.2* (0.7) -6.8* (0.5) 10 -6.5*  (0.3) 10 
PCB 153 -7.3* (0.7) -8.0* (0.5) 8 -7.5*  (0.3) 9 
Mono-ortho PCB TEQd,f -6.9* (0.7) -7.4* (0.5) 9 -6.8*  (0.3) 10 
Non-ortho PCB TEQe,f -6.1* (0.9) -6.5*  (0.7) 10 -7.4* (0.4) 9 
PCDD TEQf -6.0* (0.7) -6.7*  (0.5) 10 -8.2*  (0.3) 8 
PCDF TEQf -3.7* (0.8) -4.6*  (0.6) 15 -5.4* (0.4) 12 
BDE-47 -4.2* (1.1) -4.3*   (1.1) 16 -8.6* (0.7) 8 
BDE-99 -7.6* (1.2) -7.5*  (1.2) 9 -9.7*  (0.7) 7 
BDE-100 -0.9 (1.3) -1.2  (1.2) - -4.8*  (0.7) 14 
BDE-153 +4.9* (0.8) +4.9*  (0.7) -15 +1.1*  (0.5) -64 
SumPBDEg -1.7 (1.0) -2.0*  (0.9) 34 -5.3* (0.5) 13 
aResults of simple linear regression of the association between ln-transformed POP levels and the year of 
sampling. bResults of multiple linear regression of the association between ln-transformed POP levels and 
year of sampling. Variables adjusted for maternal age, pre-pregnancy BMI and body weight change during 
pregnancy and after delivery. cEstimated time (years) for the concentrations to be halved in the population. 
Negative values indicate the estimated time (years) for the concentrations to be doubled in the population. 
dSum of PCB 105, PCB 118, PCB 156 and PCB 167 TEQs. eSum of PCB 77, PCB 126 and PCB 169 TEQs. 
fTEQs calculated with TEFs from 2006 (Van den Berg et al. 2006). gSum of BDE-47, BDE-99, BDE-100, 
BDE-153 and BDE-154. SE, standard error. *p≤0.05 
 
 
3.1.2 PBDEs 
Dissimilar temporal trends were observed for the different PBDE congeners during the 
study period. The concentrations of BDE-47 and BDE-99 decreased, whereas the levels 
of BDE-153 increased; no significant trend was observed for BDE-100 (Table 3). Overall, 
this resulted in a small but significant decrease in the concentration of sumPBDE (sum of 
BDE-47, BDE-99, BDE-100, BDE-153 and BDE-154) between 1996 and 2006 (2% per 
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year). When data from 2008-2010 were added (Lignell et al. 2012), the declining rates for 
BDE-47, BDE-99 and sumPBDE increased and the decreasing trend for BDE-100 
became significant (Table 3, Figure 5). In addition, the increase in levels of BDE-153 
seems to have leveled out. Consequently, risk management measures taken to reduce the 
emissions of PBDEs to the environment in the beginning of the 2000s have already 
resulted in decreased human exposure levels. 
 
 
 
Figure 5. Temporal trends (1996-2010) of PCB 153 (N=398), non-ortho PCB TEQs (sum of PCB 77, 126, 
169 TEQs) (N=269), PCDD TEQs (N=235), PCDF TEQs (N=235), BDE-153 (N=353) and sumPBDE (sum 
of BDE-47, -99, -100, -153 and -154.) (N=353) in breast milk from first-time mothers in the POPUP cohort. 
TEQs have been calculated using TEFs from 2006 (Van den Berg et al. 2006). Each point corresponds to the 
contaminant level in an individual milk sample. The lines represent regression lines from analyses that 
included maternal age, pre-pregnancy BMI, weight gain during pregnancy and weight loss after delivery as 
explanatory variables. 
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Different technical mixtures as sources of PBDEs may explain the observed differences in 
temporal trends between congeners. The use of mixtures containing lower brominated 
congeners (e.g., BDE-47 and BDE-99) has been reduced voluntarily since the 1990s, 
resulting in decreasing exposure of humans. However, the use of mixtures with higher 
brominated congeners (e.g., BDE-153) was probably not reduced until the restriction by 
law in the beginning of 2000. Because BDE-153-containing products are probably still 
present on the market and in homes/workplaces, the reduced use is still not possible to 
detect in the human body. Another explanation to account for the differences in temporal 
trends between lower brominated congeners and BDE-153 may be a higher persistence of 
higher brominated congeners (Geyer et al. 2004). 
 
 
 
Figure 6. Levels of PCB 153 and sumPBDE in breast milk from Swedish mothers from 1972 to 2010. 
Results from Stockholm represent analysed levels in pooled breast milk samples (one sample per year) 
(Meironyte et al. 1999; Meironyté Guvenius 2002; Norén and Meironyte 2000), and results from Uppsala 
are yearly median levels from the POPUP study.  
 
 
Consistent with our results, a study of pooled breast milk samples from Stockholm 
showed that the levels of PBDEs in human milk have decreased since the middle of the 
1990s after an increase during the 1970s and 1980s (Figure 6). Also in agreement with 
our results, Swedish market basket studies performed in 1999 and 2010 showed that 
exposure to BDE-47 and BDE-99 from food was significantly lower in 2010 than in 1999 
(NFA 2012).  
 
Inclusion of lifestyle factors in the regression models did not affect the temporal trends for 
PBDEs (Table 3). BDE-153 was the only congener that showed a significant association 
with maternal age. This finding supports the hypothesis that BDE-153 is more persistent 
in the human body than the lower brominated congeners. 
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3.2 DETERMINANTS OF BODY BURDENS OF POPs (PAPER II) 
In Paper II, we identified factors that are important determinants of body burdens (breast 
milk levels) of PCBs, PCDD/Fs and PBDEs in mothers from the POPUP cohort. Mothers 
who were recruited in 1996-2006 (N=325) were included. 
 
3.2.1 Clustering analysis and grouping of substances 
Based on correlations between levels of single compounds/congeners in breast milk, the 
cluster analysis formed distinctly separate groups of compounds (see Figure 1, Paper II). 
These groups/clusters were most probably dependent on routes of exposure and structural 
similarities of the molecules. More specifically, PBDEs were separated from the 
chlorinated compounds at the highest hierarchical level, probably because of differences 
in routes of exposure. Food is the major exposure pathway for PCDD/Fs and PCBs, 
whereas both food and indoor dust are important contributors to the total exposure to 
PBDEs (Johnson-Restrepo and Kannan 2009; Liem et al. 2000). Among the chlorinated 
compounds, PCB 28 was organized as an outlier with low similarity to the other PCBs, 
which may be because of a faster metabolism of this low-chlorinated congener and 
because of differences in exposure routes. Building materials may give a significant 
contribution to the exposure to PCB 28 among individuals living in buildings with 
materials containing PCBs (Schwenk et al. 2002). The PCB and PCDD/F congeners 
formed clusters depending largely on the number and positions of the chlorines on the 
molecules, indicating that differences in toxicokinetics in the human body affects 
concentration patterns. 
 
3.2.2 Determinants of POP levels in breast milk  
The basic regression model showed that breast milk levels of PCBs and PCDD/Fs were 
significantly associated with maternal age, sampling year, pre-pregnancy BMI, weight 
gain during pregnancy and weight loss after delivery (Figure 7). PCB 28, however, was 
not associated with age and BMI. A higher maternal age and a larger weight loss during 
the period from delivery to milk sampling predicted higher breast milk levels of PCBs and 
PCDD/F TEQs. These levels decreased with increasing sampling year, pre-pregnancy 
BMI and weight gain during pregnancy. Higher level of education was associated with 
higher breast milk levels of non-ortho PCB TEQs and PCDF TEQs. 
 
Sampling year and maternal age explained the largest part of the variation in breast milk 
levels (17-33%). Temporal trends are discussed in Paper I (see section 3.1). Higher body 
burdens of PCBs and PCDD/Fs in older women are expected because of the accumulation 
of these substances in the body during the lifetime of the individual. The lack of 
association between PCB 28 levels and age in the POPUP cohort indicates that PCB 28 is 
less persistent than other PCBs and PCDD/Fs. It also points to the importance of recent 
exposure from, for instance, building materials in the environment. High pre-pregnancy 
BMI, probably an indication of recent weight gain, and a large weight gain during 
pregnancy may have caused a dilution of POPs because of an increased amount of body 
fat. On the other hand, large weight loss after delivery could have caused a mobilization 
of POPs from lost body fat. It can be speculated that women with different levels of 
education have different dietary habits, leading to differences in exposure to some POPs. 
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Similarly, as with most PCBs and PCDD/Fs, BDE-153 showed significant associations 
with all independent variables in the basic model. The resemblance between BDE-153 
and the chlorinated POPs could at least partly be due to a longer half-life of BDE-153 in 
the body than of the lower brominated PBDEs studied (BDE-47, -99 and -100). 
 
 
 
Figure 7. PCB 153 in breast milk versus maternal age (left panel) and pre-pregnancy BMI (right panel) in 
women from the POPUP cohort. Data from 2008-2010 has been added to the dataset that was used for Paper 
II, total N=413. Trend lines obtained from simple linear regression analyses are shown. 
 
 
Other factors examined additional to the variables in the basic regression model were 
smoking and alcohol consumption during pregnancy, breastfeeding during infancy, 
childhood on the east coast or in a fisherman family, physical activity, computer usage 
and consumption of food of animal origin. Some of the observed significant associations 
obtained are discussed below. In most cases they were weaker and less consistent than the 
associations found with the variables in the basic model.  
 
Breastfeeding is an important source of early POP exposure. In this respect, our results 
showed that women who had been breastfed during infancy had 12-22% higher levels of 
some PCBs and PCDF TEQs in their milk than women who had not been breastfed 
(Figure 8). Most of the participating mothers were born in the 1960s and 1970s when the 
levels of PCBs and PCDD/Fs in breast milk were about 10 times higher than today. Our 
results indicate that exposure that the women got from breastfeeding can still be detected 
in the body at the approximate age of 30. PCBs and PCDD/Fs may thus be persistent 
enough to be transferred between three generations, from grandmother to grandchild, 
through the breastfeeding pathway. 
 
Women who lived on the east coast of Sweden during their childhood had higher levels of 
non-ortho PCB TEQ and PCDD/F TEQ in their milk than women who grew up elsewhere 
in Sweden. This may be explained by a higher consumption of contaminated fish early in 
life owing to the higher availability on the east coast of fatty fish from the Baltic Sea 
(Rylander et al. 1997). Consequently, food habits during childhood are important for the 
body burden of PCBs and PCDD/Fs decades later in life. 
 
Investigating associations between dietary habits and POP levels in breast milk, we found 
that women with the highest consumption of fatty Baltic fish during the year before 
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pregnancy had 11-16% higher levels of mono-ortho PCB TEQ, PCDF TEQ and BDE-153 
in their milk than women who did not consume such fish (Figure 8). These results 
confirm that contaminated fish from the Baltic Sea may be an important source of 
exposure. The consumption of fatty Baltic fish in the women with the highest 
consumption was 2-21 g/day, which corresponds to 6-61 portions (125 g fish/portion) per 
year. These women exceeded the current advice to women in childbearing age regarding 
consumption of contaminated Baltic Sea fish (not more than 2-3 times per year). Several 
other studies have reported positive associations between body burdens of PCBs and 
PCDD/Fs and consumption of fatty Baltic fish (Jonsson et al. 2005; Rylander et al. 2009; 
Svensson et al. 1995) or fish in general (e.g., Agudo et al. 2009; Schade and Heinzow 
1998). 
 
 
Figure 8. POP concentrations in breast milk (adjusted geometrical mean ± standard error) from women who 
were breastfed or were not breastfed during infancy (N=263 and 29, respectively) (left) and from women 
with different consumption rates of fatty fish from the Baltic Sea (no consumption, N=171; 0.7-1.9 g/day, 
N=69; 2.0-21 g/day, N=53) (right). The results are adjusted for all variables that were significantly 
associated with milk concentrations of POPs in step 1 and 2 in the regression analyses. The concentrations 
are given in ng/g milk fat (PCB 153, di-ortho PCB, BDE-47, BDE-153) or pg/g milk fat (mono-ortho PCB 
TEQ, PCDF TEQ, total TEQ). *p<0.05 in a general linear model compared with the reference group (1st 
category). The figure is obtained from Paper II (Lignell et al. 2011) and reproduced by permission of The 
Royal Society of Chemistry. 
 
 
Collectively, the results suggest that a woman who grew up on the east coast of Sweden 
and had a small weight increase during pregnancy (25th percentile), a fast weight loss 
shortly after delivery (75th percentile) and a high current consumption of fatty Baltic fish 
(2-21 g/day) would have 40-50% higher levels of dioxins in her breast milk compared 
with a woman who did not grow up on the east coast of Sweden with an average weight 
gain during pregnancy, an average weight loss after delivery and no consumption of fatty 
Baltic fish. Following current recommendations for the consumption of contaminated fish 
from the Baltic Sea, having a normal weight gain during pregnancy and avoiding fast 
weight loss soon after delivery are feasible advice to women in order to limit dioxin levels 
in breast milk. 
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3.3 PRENATAL EXPOSURE TO POPs AND BIRTH WEIGHT (PAPER III) 
 
In Paper III, associations between prenatal exposure (i.e. breast milk levels) to di-ortho 
PCBs and sumPBDE (sum of BDE-47, BDE-99, BDE-100 and BDE-153) and birth 
weight were investigated. Participants who were recruited in 1996 to 2010 were included. 
Breast milk levels of di-ortho PCBs and PBDEs were available for 416 and 364 mothers, 
respectively. 
 
3.3.1 PCBs and birth weight 
The multivariate regression model showed a weak but significant positive association 
between prenatal exposure to di-ortho PCBs and birth weight (Table 4). The mean 
increase in birth weight was 137 g (95% confidence interval, CI: 17-257) for every 1-unit 
increase in ln-transformed di-ortho PCB concentration, corresponding to a mean 
difference in birth weight between the 25th and 75th percentile of exposure of approxi-
mately 100 g. 
 
 
Table 4. Associations between exposure to di-ortho PCBs and PBDEs and birth weight. Results obtained 
from Paper III (Lignell et al. 2013a). 
 All participants Female infants Male infants 
 βa SEb N βa SEb N βa SEb N 
Multivariate modelc          
 di-ortho PCBsd 137* 61 346 42 99 161 200* 77 185 
 sumPBDEe -54 46 346 32 70 161 -126* 62 185 
Multivariate model including gestational lengthf    
 di-ortho PCBsd 143* 65 254 149 123 110 141# 77 144 
 sumPBDEe -106* 52 254 -47 93 110 -139* 64 144 
aRegression coefficient, i.e. change in birth weight per 1-unit increase in ln-transformed contaminant 
concentration in breast milk. bStandard error. cDi-ortho PCB and sumPBDE were included in the same 
model. Other covariates included were age of the mother, pre-pregnancy BMI, weight gain during 
pregnancy, education, smoking and infant sex. Infant sex was not included in the separate analyses for 
female and male infants. dSum of PCB 138, PCB 153 and PCB 180. eSum of BDE-47, BDE-99, BDE-100 
and BDE-153. fGestational length was added to the covariates in the multivariate model. *p≤0.05 #p≤0.10 
 
 
In contrast to our results, accidental exposures to very high levels of PCBs or PCDD/Fs 
have been shown to decrease birth weight (Tsukimori et al. 2012). Results from studies of 
background exposure to PCBs and birth weight are inconsistent, where some report 
inverse associations (e.g., Halldorsson et al. 2008; Patandin et al. 1998; Hertz-Picciotto et 
al. 2005; Rylander et al. 1998), while others report no significant associations (e.g., 
Gladen et al. 2003; Longnecker et al. 2005; Weisskopf et al. 2005). Generally, the PCB 
exposure levels in studies showing inverse associations were higher than in the POPUP 
cohort. One possible explanation for the discrepancies between studies is that the dose-
effect curve is non-monotonic with a positive low-dose effect of di-ortho PCBs on birth 
weight and a negative effect at higher exposure levels. However, it can also be speculated 
that observed inverse associations in some studies may be partly confounded by maternal 
pre-pregnancy BMI and weight gain during pregnancy. The observed positive association 
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between di-ortho PCB exposure and birth weight in our study was only significant when 
both these covariates were included in the regression model. Increased pre-pregnancy 
BMI and maternal weight gain are both associated with increased birth weight as well as 
with decreased levels of PCBs in breast milk and maternal blood (Glynn et al. 2007; 
Lignell et al. 2011). Thus, these variables are important confounders. Few other studies on 
PCB exposure in relation to birth weight adjust their results for maternal weight gain, but 
we suggest that both BMI and weight gain should be considered in future studies. Using a 
pharmacokinetic model, Verner et al. (2013) found that previously reported inverse asso-
ciations between exposure to PCB 153 and birth weight may be due to confounding by 
gestational weight gain. 
 
In addition to maternal BMI and weight gain, concurrent exposure to sumPBDE was also 
important to include in the regression model in our study. It therefore seems as though 
PCBs and PBDEs influence birth weight via biochemical pathways in such way that 
exposure to PBDEs may partially mask the association between di-ortho PCBs and birth 
weight, and vice versa. Adding gestational length to the multivariate model did not 
significantly change the result for di-ortho PCB (Table 4), indicating that the association 
between di-ortho PCB exposure and birth weight was mediated by increased fetal growth 
rather than by increased gestational length. Further, the positive association was not 
appreciably changed when fish consumption during pregnancy was added to the 
regression model. 
 
Because di-ortho PCB levels in breast milk are strongly correlated with levels of DL-
PCBs, PCDD/Fs and p,p´-DDE in the POPUP cohort (see Paper III), di-ortho PCB could 
be a marker for exposure to other chlorinated POPs. It is therefore difficult to separate the 
influence of different chlorinated compounds on birth weight from each other, and if the 
observed associations are causal, it is possible that they are caused by the total mixture of 
compounds.  
 
3.3.2 PBDEs and birth weight 
Although not statistically significant, there was an inverse association between sumPBDE 
exposure and birth weight in both the unadjusted and multivariate models (Table 4). 
However, a significant association did emerge when gestational length was included in 
the regression model. The mean decrease in birth weight was 106 g (95% CI: -4 to -208) 
for every 1-unit increase in ln-transformed sumPBDE concentration, corresponding to a 
mean difference in birth weight between the 25th and 75th percentile of exposure of 
approximately 80 g. The inverse association was also significant in the multivariate model 
(without gestational length) when the analysis was restricted to individuals with data on 
gestational length (data on gestational length was missing for about one third of the 
participants) (see Table 3 in Paper III). Our data do not make it possible to draw firm 
conclusions about the reason behind the difference between the unrestricted and restricted 
analysis, but we feel it may be due to chance. However, the results suggest that the 
observed inverse association between sumPBDE and birth weight was not due to a PBDE 
influence on gestational length. If di-ortho PCB was excluded from the statistical model, 
the inverse association was not significant, again suggesting that exposure to these 
different classes of POPs may mask the effect of each other. Because of this reason, our 
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results strongly suggest that it is important to control for concurrent exposure to different 
contaminants (such as PCBs and PBDEs) in studies of POPs and birth weight. 
 
There are few other studies on the association between PBDE exposure and birth weight 
showing diverging results. Only two larger studies that also adjusted their results for 
possible confounders were found (Foster et al. 2011; Harley et al. 2011). Both of these 
studies show inverse associations. However, in one of the studies the significance levels 
did not persist when controlling for maternal weight gain (Harley et al. 2011). 
 
The association between sumPBDE and birth weight became stronger when fish 
consumption was included in the multivariate model: β decreased with 29% from -106 to 
-137. Fish consumption is the major contributor to the dietary intake of PBDEs. Indeed, 
maternal seafood consumption has been positively associated with birth weight in several 
observational studies (Brantsaeter et al. 2012). Our results indicate that fish consumption 
may be a confounder of the association between PBDE exposure and birth weight because 
of its positive association with both exposure and outcome. 
 
3.3.3 Sex differences 
When female and male infants were studied separately, the multivariate model showed a 
significant positive association between di-ortho PCB and birth weight in male infants, 
but not in females (Table 4). Similarly, the inverse association between sumPBDE and 
birth weight was only observed in male infants. These sex differences may be due to 
chance or to a smaller number of female infants in the study (161 females and 185 males). 
However, it is also possible that male fetuses are more vulnerable to PCB and PBDE 
exposure than females. Other studies have shown an inverse association between PCBs 
(or POPs in general) and birth weight restricted to male infants (Hertz-Picciotto et al. 
2005; Rylander et al. 1995; Sonneborn et al. 2008). 
 
In conclusion, the present relatively large study of background prenatal exposure to di-
ortho PCBs and sumPBDE indicates that these substances may influence birth weight in 
different directions. Exposure to di-ortho PCBs tended to be associated with higher birth 
weight, whereas the association between sumPBDE and birth weight was inverse. Both 
high and low birth weight has been linked to such risk factors as overweight, hypertension 
and insulin resistance later in life (Calkins and Devaskar 2011; Parsons et al. 1999). One 
could therefore speculate that, if causal, the small PCB- and PBDE-induced shifts in birth 
weight distribution may influence future public health in populations with background 
exposure. This influence could be especially important in boys in the lower or upper ends 
of the birth weight distribution. 
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3.4 POP EXPOSURE AND THYROID HORMONES (PAPER IV AND V) 
Several possible associations between POP exposure (maternal body burdens and 
estimated pre-and postnatal exposure of infants) and levels of thyroid hormones in 
mothers and infants were investigated and presented in Paper IV and V (Table 2). 
Women who donated blood during pregnancy (recruited in 1996-1999) were included. 
Blood was also sampled from their infants after birth. Most associations were weak and 
non-significant. Presented below are the significant results that I found worthy of 
discussion and further thought. For a more comprehensive presentation of the results, the 
reader is referred to Paper IV and V. 
 
3.4.1 POP body burdens and thyroid hormones in pregnancy 
Simple linear regression models showed significant inverse associations between 
maternal body burdens of di-ortho PCBs, mono-ortho PCB TEQs, PCDD/F TEQs and 
total T3 in early and late pregnancy (Figure 9). After adjusting for possible confounders, 
the only significant association was for PCDD/F TEQ. In early pregnancy the decrease in 
total T3 level was 0.54±0.21 nmol/L serum (mean±standard error) for every 1-unit 
increase in maternal PCDD/F TEQ breast milk level (N=66) (Paper V). The correspond-
ing value in late pregnancy was 0.39±0.12 nmol/L serum (N=91) (Paper IV). 
 
 
 
Figure 9. Crude associations between maternal breast milk levels of PCDD/F TEQ and maternal serum 
levels of total T3 (TT3) in early pregnancy in the POPUP cohort (N=67). Figure obtained from Paper V 
(manuscript). 
 
 
The inverse association between breast milk levels of PCDD/F TEQ and maternal levels 
of total T3 was significant in both early and late pregnancy and persisted after covariate 
adjustment. These results are in accordance with studies in laboratory animals in which 
TT3=3.52-0.55*lnPCDD/F TEQ, p<0.001
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PCBs and PCDD/Fs have been shown to reduce the levels of circulating thyroid 
hormones (Boas et al. 2009). Although results from epidemiological studies differ, an 
inverse relationship between background exposure to chlorinated POPs and levels of T3 
or T4 has been reported in several publications (Alvarez-Pedrerol et al. 2009; Chevrier et 
al. 2008; Koopman-Esseboom et al. 1994; Takser et al. 2005).  
 
Thyroid hormones are essential for normal brain development. The fetus is dependent on 
the maternal supply of thyroid hormones and even mild reductions in maternal hormone 
levels during critical periods of brain development may affect children’s cognitive 
development (Patel et al. 2011; Trumpff et al. 2013). Although the observed association 
between PCDD/F TEQ and total T3 in our study was weak, our findings add to the 
literature that suggests that exposure to chlorinated POPs may decrease levels of thyroid 
hormones in pregnant women. If the observed inverse associations in our and other 
epidemiological studies are causal, they may be of importance for neurological 
development. Maternal thyroid hormone levels during pregnancy may also affect thyroid 
hormone status in children in later life (Pakkila et al. 2013). 
 
For PBDEs, there were no associations with maternal thyroid hormone levels that were 
consistent in early and late pregnancy. In early pregnancy BDE-153 in breast milk was 
inversely associated with total T3 in the crude and adjusted regression models (Paper V). 
The decrease in the total T3 level in the adjusted model was 0.20±0.08 nmol/L serum 
(mean±standard error) for every 1-unit increase in maternal BDE-153 breast milk level 
(N=126). In late pregnancy there was a significant inverse association between BDE-99 
and TSH that persisted after covariate adjustment (β=-0.17±0.09, N=166) (Paper V). 
Taken together, our results on the association between PBDE exposure and thyroid 
hormone levels in pregnant women were weak and inconsistent. 
 
 
3.4.2 POP exposure and thyroid hormones in infants 
Associations between fetal and postnatal exposure to PCBs, PCDD/Fs, p,p’-DDE and 
PBDE and thyroid hormone levels in infants were non-significant in most cases. The only 
significant association that also persisted after covariate adjustment was an inverse 
association between maternal late pregnancy serum levels of LPCBs (sum of the low-
chlorinated congeners CB-28, 52 and 101) and total T3 in infants at 3 weeks of age (Paper 
IV). Because the levels of LPCB were below LOQ in many women, this exposure 
variable was categorized in quartiles. The adjusted mean level of total T3 was 9% lower 
in infants in the highest exposure quartile compared with infants in the reference quartile 
with the lowest exposure.  
 
In the US-EPA risk assessment of non-cancer effects of TCDD the RfD was based on 
increased levels of TSH in newborns exposed to high levels of TCDD in utero (US-EPA 
2012). Results from other studies on the association between background POP exposure 
and thyroid hormone status in infants are inconclusive. Some studies found inverse 
associations between PCB exposure (mainly di-ortho congeners) and levels of thyroid 
hormones in cord blood (Herbstman et al. 2008; Maervoet et al. 2007). However, it is not 
possible to reach a conclusion about associations between background POP exposure and 
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thyroid hormone levels in infants. The exposure levels and the statistical power (i.e. 
number of participants) in the POPUP cohort may be too low to detect effects on 
thyroid hormone status in infants. 
 
 
3.5 POP EXPOSURE VERSUS HEALTH-BASED GUIDANCE VALUES 
In this section, exposure to DL compounds and PBDEs in mothers and infants in the 
POPUP cohort is compared with health-based guidance values from the risk assessments 
discussed in section 1.4.1. 
 
3.5.1 PCBs and PCDD/Fs 
The TWI for dioxins and DL-PCBs established by the European SCF (14 pg TEQ/kg 
body weight) was based on developmental effects in male rats after exposure in utero 
(SCF 2001). The TWI was set to protect fetuses from harmful exposure levels. The 1-
compartment, first-order elimination pharmacokinetic model used by the SCF was applied 
to estimate the steady-state body burden in humans at the TWI level:  
 
Body burden (ng/kg bw) = f * intake (ng/kg bw/day) * half-life (days) / ln(2) 
 
where f is the fraction of dose absorbed, which is assumed to be 50% for absorption of 
dioxins from food for humans. The estimated half-life of the elimination of dioxins is set 
to 2740 days (SCF 2001). This calculation resulted in an estimated TWI body burden of 
4.0 ng TEQ/kg body weight, or, assuming 30% fat in women aged about 30 years (ICRP 
2002) and a complete distribution of the compounds to this body fat, 13 ng/kg body fat. 
The median total TEQ level in breast milk from the POPUP cohort (1996-2010) is only 
slightly lower than the TWI body burden, i.e. 10 ng/kg lipids (range: 1.6-31). Thirty-one 
percent of the women exceeded the estimated TWI body burden during the study period. 
However, the levels of dioxins and DL-PCBs in breast milk decreased between 1996 
and 2010. The median total TEQ level in breast milk sampled in 2008-2010 (5.9 ng/kg 
lipids) was about half of the TWI body burden. In addition, breast milk from 5% of the 
women had higher total TEQ levels than 13 ng/kg lipids. Using the RfD for TCDD as 
proposed by the US-EPA (0.7 pg/kg body weight/day) (US-EPA 2012) instead of the 
TWI, a RfD steady-state body burden can be estimated to 4.6 ng/kg body fat. The 
median breast milk level of total TEQ in the POPUP cohort in 2008-2010 exceeded this 
RfD body burden. Moreover, 75% of the women had higher total TEQ levels than 4.6 
ng/kg lipids in their breast milk. 
 
To estimate the intake of dioxins and DL-PCBs in breastfed infants in the POPUP cohort 
we used a mean consumption of 700 g breast milk per day in a one-month old infant of 
4.5 kg (Niklasson and Albertsson-Wikland 2008; Sievers et al. 2002), a mean lipid level 
in breast milk of 3% (mean level in the POPUP cohort) and total TEQ levels in breast 
milk from the mothers recruited in 2008-2010. The median daily intake in breastfed 
infants is estimated to 28 pg TEQ/kg body weight (range: 7.5-102). This intake level far 
exceeds the RfD of 0.7 pg TEQ/kg body weight/day and also exceeds 20 pg/kg body 
weight/day which is the estimated intake at the LOAEL for decreased sperm count and 
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motility that was used by the US-EPA to derive the RfD (US-EPA 2012). The LOAEL 
was based on a study of men who were 1-9 years old at the time of exposure and it is not 
known if exposure to DL compounds during breastfeeding will cause similar effects. 
Exposure to DL compounds in utero seems to be most critical for health, but the US-EPA 
risk assessment shows that exposure after birth may also be of importance for later health 
development. 
 
Because the breastfeeding period is short, the European SCF and the WHO have 
concluded that possible risks from high exposure to DL compounds from breast milk are 
outweighed by the beneficial effects of breastfeeding (SCF 2001; WHO 2000a). Breast-
feeding clearly lowers the risk of death from infectious diseases (mostly gastrointestinal 
and respiratory tract infections) in both developed and developing countries (Hornell et al. 
2013; Quigley et al. 2007; WHO 2000b). The evidence for long-term beneficial health 
effects of breastfeeding during childhood is weaker and sometimes controversial. 
However, decreased risks of overweight/obesity, type-2 diabetes and atopic diseases, 
reduced systolic blood pressure and total blood cholesterol, as well as beneficial effects 
on IQ in children and adolescents have been suggested (Hornell et al. 2013; Horta and 
Victora 2013).  
 
3.5.2 PBDEs 
Although available data did not allow for determination of health-based tolerable intake 
levels, BMDL10-body burdens (µg/kg body weight) for neurodevelopmental effects of 
PBDEs in mice were derived in the risk assessment performed by the EFSA (EFSA 
2011). Assuming 30% fat in women aged approximately 30 years (ICRP 2002) and a total 
distribution of the compounds to this body fat, these BMDL10-body burdens can be 
estimated to 770 (BDE-47), 30 (BDE-99) and 210 (BDE-153) µg/kg body lipids. Median 
breast milk levels of BDE-47, BDE-99 and BDE-153 in the POPUP cohort (2008-2010) 
make up less than 0.5% of the estimated BMDL10-body burdens. 
 
The EFSA calculated that chronic human daily intake levels associated with the BMDL10-
body burdens were 172 (BDE-47), 4.2 (BDE-99) and 9.6 (BDE-153) ng/kg body weight 
(EFSA 2011). In breastfed infants in the POPUP cohort (2008-2010) the median daily 
intake of these congeners can be estimated to 2.5 ng/kg body weight for BDE-47 (range: 
0.4-56), 0.5 ng/kg body weight for BDE-99 (range: 0.02-6.4) and 2.3 ng/kg body weight 
for BDE-153 (range: 0.6-22) (consumption of 700 g breast milk per day in a one-month 
old infant weighing 4.5 kg). Median exposure to PBDEs in breastfed infants in the 
POPUP cohort is thus lower than the estimated BMDL10 intake levels, but the margins are 
small, especially for BDE-99 and BDE-153. Variation in breast milk levels between 
individuals is large and infants exposed to the highest levels will exceed the BMDL10 
intake levels for BDE-99 and BDE-153 established from studies of neonatally exposed 
mice.  
 
3.5.3 Conclusions 
Most women in the POPUP cohort have body burdens of DL compounds below the 
estimated body burden at the current TWI level adopted within the EU. However, the 
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margin to the estimated TWI body burden is small and most women exceed the estimated 
body burden at the RfD proposed by US-EPA. It is therefore desirable that body burdens 
of DL compounds continue to decrease to reduce fetal exposure. It is also desirable to 
reduce the exposure of breastfed infants to both DL compounds and PBDEs because 
exposure early in life may have important consequences for health. Based on reduced risk 
for infections, the WHO recommends exclusive breastfeeding during the first six months 
of life and extended complimentary breastfeeding until two years of age (Horta and 
Victora 2013; WHO and UNICEF 2003). In Sweden, the NFA has adopted the WHO 
recommendation of six months of exclusive breastfeeding. Lower levels of DL 
compounds and PBDEs would improve the quality of the breast milk and may also 
increase the beneficial effects associated with breastfeeding.  
 
In order to decrease human exposure, efforts to reduce contamination of the environment 
and of food with DL compounds and PBDEs should be continued. Fish is the major 
dietary source of exposure. In addition, fish is the principal source of n-3 long-chain poly-
unsaturated fatty acids (n-3 LC-PUFA) suggested to have a protective effect against 
cardiovascular disease and to improve neurodevelopment in infants and young children 
(FAO/WHO 2011). Accordingly, lower levels of DL compounds may increase the benefi-
cial effects associated with nutrients present in fish.  
 
Reduced levels of PBDEs in food are important, but a general reduction of PBDE levels 
in the human environment (i.e. in indoor air and dust) is of equal importance. As shown 
by correlations between levels of PBDEs in house dust and breast milk (Bjorklund et al. 
2012; Wu et al. 2007), the indoor environment is an influential exposure route for PBDEs. 
 
 
3.6 GENERAL METHODOLOGICAL CONSIDERATIONS 
The study on the association between exposure to POPs and birth weight (Paper III) and 
parts of the study on thyroid hormones (Paper IV-V) presented in this thesis are cross-
sectional, i.e. exposure and outcome were measured at the same time point. Most other 
studies in this field have also employed a cross-sectional design. An inherent drawback of 
the cross-sectional approach is that it is not possible to conclude whether the observed 
associations are causal. For instance, PCDD/F exposure may affect the level of total T3 in 
blood in pregnant women in the POPUP cohort, but reverse causality, i.e. an effect of 
thyroid hormone status on the levels of PCDD/F in the body, cannot be excluded. To be 
able to draw conclusions about causality exposure (maternal body burdens of POPs) could 
be measured before pregnancy in studies of associations between POP exposure and 
health outcomes in pregnant women and newborns. Such a study design would eliminate 
the risk that the large changes in metabolism and body composition that occur during 
pregnancy will affect the results.  
 
In our study the exposure (POP levels in breast milk) was even measured after the 
outcome (birth weight, thyroid hormone levels during pregnancy). However, POP 
concentrations in breast milk and maternal blood are highly correlated, and breast milk 
levels give a good estimate of the maternal body burden during pregnancy and thus of the 
exposure of the infant during the fetal period. Samples of both breast milk and late 
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pregnancy blood serum were collected from some of the women in the POPUP study. 
Both sample types were analysed for PCBs and p,p’-DDE. Correlations between 
contaminant levels in serum and milk were strong (Figure 10). In the POPUP cohort 
strong correlations have also been observed between PBDE levels in breast milk and 
serum collected at the same time point (Lignell et al. 2013b). In addition, other studies 
have shown strong correlations between late pregnancy serum and breast milk levels of 
PBDEs (Needham et al. 2011). All these findings indicate that PBDE levels in breast milk 
can be used as an indicator of maternal body burden and probably of prenatal exposure. 
 
 
 
 
Figure 10. Correlations between serum (late pregnancy) and breast milk levels of di-ortho PCBs and p,p’-
DDE in first-time mothers from the POPUP cohort (N=202). Pearson correlation coefficients are shown. 
 
 
A major strength of this thesis concerns the relatively large number of participants. 
Precision is thus high in comparison with many other studies in this field. Another 
strength is that data on several lifestyle factors, including dietary habits, were available 
from the participants in the POPUP cohort. This availability of data enabled us to adjust 
the results in study III-V for a number of possible confounders. Variables that were 
chosen as covariates were either known to predict exposure (i.e., POP levels in breast 
milk), associated with the outcome (birth weight or thyroid hormone levels), or often 
included in similar studies. In paper V, only variables that were significantly associated 
with the outcome in bivariate models were selected as confounders. 
 
3.6.1 Exposure assessment 
Exposure assessment is often a critical determinant of the validity of epidemiological 
studies. An important strength of the POPUP study is the high quality of the exposure 
assessment, including chemical analysis of contaminants in individual breast milk or 
serum samples. Because chemical analyses of POPs are expensive, some studies in this 
field use fish consumption as a proxy for POP exposure. However, at least in the POPUP 
cohort, this is not a valid measurement of exposure because fish consumption only 
explains a small portion of the variation of body burden of POPs (Paper II). 
 
Several chlorinated POPs (dioxins, DL-PCBs, NDL-PCBs, p,p’-DDE) as well as PBDEs 
were analysed in the samples from the POPUP cohort. Levels of the chlorinated 
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compounds are highly correlated because of similar sources of exposure and toxico-
kinetics in the human body. Hence, identifying the effect associated with, or caused by, a 
specific chlorinated compound is difficult. Moreover, other unmeasured compounds may 
contribute to the observed effects and interaction between chemicals may occur. The 
observed association between di-ortho PCB exposure and birth weight (Paper III) could 
seemingly be the result of exposure to the whole mixture of chlorinated compounds. 
PBDE levels in breast milk are to some extent correlated to the chlorinated compounds, 
but the correlations are much weaker. The analyses of both chlorinated compounds and 
PBDEs made it possible to adjust associations for concurrent exposure to these different 
groups of contaminants (Paper III). The results in Paper III show that it may be important 
to adjust for concurrent exposure to different contaminants.     
 
3.6.2 Generalizability 
Mothers in the POPUP cohort were randomly recruited among first-time mothers in 
Uppsala County. Both the mother and the child had to be healthy and the mother had to be 
born in a Nordic country to be included. During the study period, the participating rate 
varied between 42 and 82%. The age of the participants (mean 29.1 years in 2008-2010) 
was comparable with the mean age of all first-time mothers in Sweden (28.4 years in 
2008-10) (Socialstyrelsen 2012). Since 2000, women who declined to participate were 
asked about their education. We found that participants generally had a higher level of 
education than non-participants. This may to some extent have influenced the results 
because of differences in lifestyle, i.e. dietary habits, between populations with different 
levels of education (Amcoff et al. 2012). 
 
To study regional differences in breast milk levels of POPs, first-time mothers have been 
recruited not only in Uppsala but also in other Swedish cities: Lund, Gothenburg and 
Lycksele (Glynn et al. 2011). Breast milk from these studies have been analysed for 
PCBs, p,p’-DDE and PBDEs. The results revealed small differences in contaminant levels 
between regions, indicating that POP exposure of the general population in Sweden is 
similar in different parts of the country (Glynn et al. 2011). The results presented in this 
thesis can thus be generalized to Swedish first-time mothers. 
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4 CONCLUSIONS 
 
• Levels of PCBs and PCDD/Fs in breast milk from Swedish first-time mothers in the 
POPUP cohort have decreased by about 4-8% per year from 1996 to 2010. Temporal 
trends of PBDEs varied depending on congener studied, with decreasing levels of 
tetra- and penta-brominated congeners (BDE-47, -99, -100) (5-10% per year) and 
slightly increasing levels of the hexa-brominated BDE-153 (+1% per year). The 
decreasing trends for chlorinated POPs and lower brominated PBDEs show that 
efforts to reduce contamination of the environment and food have resulted in 
decreased human exposure levels. 
 
• Factors that predicted higher levels of PCBs and PCDD/Fs in breast milk were high 
maternal age and fast weight loss after delivery. In contrast, high pre-pregnancy BMI 
and large weight gain during pregnancy predicted lower levels. Women who were 
breastfed during infancy, grew up on the east coast of Sweden (with high availability 
of contaminated fish from the Baltic Sea) and had a high consumption of fatty Baltic 
fish during the year before pregnancy had higher levels of some POPs in breast milk. 
These findings suggest that exposure to POPs during the whole lifetime of the 
individual is important for breast milk levels at the time of nursing. 
 
• Prenatal exposure to di-ortho PCBs was associated with higher birth weight and 
PBDE exposure was associated with lower birth weight in the POPUP cohort. Both 
high and low birth weight has been linked to overweight, hypertension and insulin 
resistance later in life. If causal, the small PCB- and PBDE-induced shifts in birth 
weight distribution may influence future public health in populations with background 
exposure. 
 
• The inverse association between PBDE exposure and birth weight proved stronger 
when maternal fish consumption was added to the statistical model, indicating that 
fish consumption may be a confounder in this relation because of its positive 
association with both exposure and outcome. 
 
• The observed associations between PCB and PBDE exposure and birth weight were 
stronger in male infants, suggesting a higher susceptibility of male fetuses to POP 
exposure. 
 
• Associations between maternal, fetal and postnatal exposure to PCBs, PCDD/Fs, p,p’-
DDE and PBDE and thyroid hormone levels in mothers during pregnancy and in 
infants after delivery were mostly weak and non-significant. However, higher mater-
nal body burdens of PCDD/Fs were associated with lower maternal levels of total T3. 
That the association was similar in early and late pregnancy strengthens its reliability. 
Thyroid hormones are essential for normal brain development. If causal, the observed 
association between PCDD/F exposure and thyroid hormone status may be of im-
portance for neurological development in children.  
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• The margin between current body burdens of DL compounds in the POPUP cohort 
and the highest levels tolerable from a health perspective is small. In addition, 
exposure to DL compounds and PBDEs in breastfed infants is high. 
 
• Based on the findings in this thesis, it is desirable that body burdens of PCBs, dioxins 
and PBDEs in young Swedish women continue to decrease to limit fetal and infant 
exposure. Efforts to reduce contamination of the environment and of the food chain 
should be continued and children and women in childbearing ages should restrict their 
consumption of contaminated fatty fish from the Baltic Sea to limit the risk of high 
exposure. In addition, women may be advised to have a normal weight increase dur-
ing pregnancy and avoid fast weight loss shortly before pregnancy or after delivery. It 
is important to continue to follow the levels of POPs in breast milk to follow up 
further efforts to reduce human exposure. 
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5 POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
Persistenta (svårnedbrytbara) organiska miljöföroreningar (POP, persistent organic 
pollutants) är en grupp kemiska ämnen som på olika sätt har fått stor spridning i miljön. 
Exempel är polyklorerade bifenyler (PCB), polybromerade difenyletrar (PBDE) och 
dioxiner. PCB har framställts för användning i bland annat elektrisk utrustning. PBDE 
används för att förhindra brand i till exempel elektronik och textilier. Dioxiner kan bildas 
vid förbränningsprocesser och vid tillverkning av vissa kemikalier.  
 
Människan får främst i sig POP via maten. För PBDE är inomhusmiljön (luft och damm) 
också en viktig källa. Eftersom POP är fettlösliga och bryts ner långsamt lagras de i 
kroppen under hela livet och förs över till fostret och det ammade spädbarnet via moder-
kakan och bröstmjölken. POP är giftiga och hög exponering kan bland annat påverka 
utvecklingen av nervsystemet, fortplantningsförmågan, immunförsvaret och hormon-
systemen. Foster och spädbarn är extra känsliga för POP. På grund av ämnenas oönskade 
egenskaper har användningen och utsläppen av PCB och dioxiner begränsats kraftigt 
sedan 1970-talet och användningen av PBDE sedan början av 2000-talet. Fet fisk från 
Östersjön (strömming, vildfångad lax) kan innehålla höga halter av dioxiner och PCB. 
Livsmedelsverket rekommenderar därför att barn och kvinnor i barnafödande ålder ska 
begränsa sin konsumtion av sådan fisk till 2-3 gånger per år. Syftet med rådet är att 
minska exponeringen av foster och spädbarn. 
 
Syftet med den här avhandlingen var att undersöka halterna av POP i kroppen hos 
svenska förstföderskor och hur halterna har förändrats över tiden. Vi ville också 
undersöka om det finns några samband mellan halterna av POP hos svenska förstföders-
kor och nivåerna av sköldkörtelhormoner i blodet hos kvinnorna och barnen eller barnens 
födelsevikt. För att kunna göra detta samlades prover av bröstmjölk och blod in från 
slumpvis utvalda förstföderskor och deras barn i Uppsala under perioden 1996 till 2010. 
Halterna av POP i modersmjölk ger ett bra mått på hur mycket POP barnet utsätts för 
under både foster- och amningsperioden. 
 
Resultaten visade att de mammor som deltog i studien hade mätbara halter av PCB, 
dioxiner och PBDE i modersmjölken. Halterna av PCB och dioxiner minskade med 4-8 % 
per år under perioden 1996-2010. Det finns flera varianter av PBDE och halterna av vissa 
av dessa minskade, medan halterna av andra ökade något. De nedåtgående trenderna tyder 
på att de åtgärder som vidtagits för att minska spridningen av PCB, dioxiner och vissa av 
PBDE-varianterna till miljön har medfört att vi människor får i oss mindre mängder av 
dessa ämnen. 
 
Äldre mammor hade högre POP-halter i bröstmjölken än yngre mammor, vilket beror på 
att ämnena lagras i kroppsfettet under hela livstiden och utsöndras i mjölken. Resultaten 
visade också att kvinnor som gick upp mycket i vikt under graviditeten hade lägre POP-
halter i mjölken än de som gick upp mindre i vikt. De kvinnor som gick ner mycket i vikt 
efter förlossningen hade däremot högre POP-halter i mjölken. Detta beror sannolikt på att 
POP späds ut i en större mängd kroppsfett när man går upp i vikt och frigörs från kropps-
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fettet vid viktnedgång. Högre halter av vissa POP uppmättes i mjölk från kvinnor som 
själva blivit ammade när de var spädbarn och från kvinnor som bodde på ostkusten under 
uppväxten (och sannolikt åt mer förorenad fet fisk från Östersjön än andra). Detta tyder på 
att de mängder POP man får i sig som barn via amning och fisk har betydelse för halterna 
i kroppen vid vuxen ålder. Konsumtionen av fisk senare i livet är också viktig och kvinnor 
som åt mycket förorenad fet fisk från Östersjön under året före graviditeten hade högre 
halter av vissa POP i sin mjölk än de som inte åt sådan fisk. 
 
Födelsevikten är ett mått på barnets hälsa under fosterperioden. Dessutom kan både låg 
och hög födelsevikt öka risken för bland annat övervikt, högt blodtryck och hjärt- och 
kärlsjukdom i vuxen ålder. Den här studien visade ett samband mellan högre exponering 
för PCB under fosterperioden och högre födelsevikt hos barnen. För PBDE var sambandet 
det omvända, d.v.s. barn med högre exponering hade något lägre födelsevikt. Skillnaden i 
födelsevikt mellan hög exponering (75:e percentilen) och låg exponering (25:e percenti-
len) var ca 100 g högre födelsevikt för PCB och 80 g lägre födelsevikt för PBDE. 
 
Sköldkörtelhormoner är viktiga för utveckling, tillväxt och ämnesomsättning. Under både 
fosterperioden och barndomen är de nödvändiga för att hjärnan ska utvecklas normalt. 
Sambanden mellan exponering för POP och nivåerna av sköldkörtelhormoner hos 
mammorna och barnen i den här studien var i de flesta fall svaga och inte statistiskt 
säkerställda. Det fanns dock ett samband mellan högre halter av dioxiner och lägre nivåer 
av sköldkörtelhormonet trijodtyronin (även kallat T3) i mammans blod. Även om 
sambandet var svagt skulle det kunna ha betydelse för hjärnans utveckling hos fostret. 
 
Resultaten i den här avhandlingen har gett viktig kunskap om halterna av POP hos 
svenska förstföderskor som är användbar när riskerna med POP i mat ska värderas. 
Marginalen mellan de POP-halter som kvinnorna hade i kroppen och de nivåer som anses 
tolerabla var i vissa fall små. Vi observerade också samband mellan POP-exponering och 
födelsevikt respektive sköldkörtelhormonnivåer som kan vara viktiga för hälsan. Slut-
satsen blir därför att det är önskvärt att halterna av dioxiner, PCB och PBDE hos svenska 
kvinnor fortsätter att minska. Viktigast är att fortsätta arbetet med att minska spridningen 
av dessa ämnen till miljön och till maten. Barn och kvinnor bör också begränsa sin 
konsumtion av fet fisk från Östersjön som kan innehålla höga POP halter. Det är viktigt 
att fortsätta följa halterna av dioxiner, PCB och PBDE i modersmjölk för att få veta om de 
åtgärder som sätts in för att minska befolkningens exponering har fått någon effekt. 
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